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Abstract 
Investigating Physiological Determinants of Mental Health in Children with Cerebral Palsy 
Background  
Fifty-seven percent of children with cerebral palsy (CP) experience mental health symptoms 
including symptoms of anxiety and depression. Although CP is non progressive, secondary 
conditions can have progressive effects on an individuals’ functional abilities. Particularly, 
untreated mental health symptoms can negatively affect a child’s quality of life. Children with 
CP also experience fatigue, pain, poor physical activity, and sleep disturbances. The presence of 
these physiological symptoms, separate and in combination, may impact mental health; however, 
it has not been systematically examined. Identifying factors that contribute to mental health 
symptoms may prevent the maintenance of these issues into adulthood.  
Objectives 
This study aimed to understand the associations between fatigue, pain, sleep, physical activity 
and mental health symptoms for children with CP. We hypothesized that moderate levels of 
fatigue, pain and/or sleep difficulties were associated with presence of psychological symptoms. 
In addition, we hypothesized that lower levels of physical activity were associated with mental 
health symptoms. 
Methods 
An observational study was conducted to assess physiological and mental health symptoms and 
physical activity in children with CP. Twenty-six participants and their caregivers responded to 
risk factor specific questionnaires before wearing accelerometers for one week, providing non-
invasive data on movement patterns and sleep cycles. Using pairwise correlations and backward 
stepwise linear regressions, we examined the associations between the risk factors and severity 
of mental health symptoms. 
Results 
Significant regression models demonstrated associations for behavioural, depressive and anxiety 
related symptoms in children with CP. Models were able to explain 61%, 18% and 41% of the 
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Conclusion 
Fatigue, pain severity, sleep efficiency and physical activity outcomes all contributed in some 
way to mental health outcomes. Longitudinal research is required to determine causal 
relationships.  
Future Applications 
This study will help develop evidence-based interventions to treat these factors and have the 
potential to inform clinicians on the determinants of mental health outcomes in this population. 
Individualized, targeted interventions can be developed and implemented to address the 
modifiable risk factors that threaten the wellbeing of children with CP. 
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Summary for Lay Audience 
Cerebral palsy (CP) is the most prevalent and most impactful long-term motor disability in 
children. As children with CP grow, they experience new or worsening symptoms, including 
mental health symptoms, that can have negative effects on their quality of life. Identifying 
factors that contribute to mental health symptoms can prevent these issues from being 
maintained into adulthood. The objective in this study was to understand the association between 
fatigue, pain, sleep, physical activity and mental health symptoms for children and youth with 
CP. We determined that fatigue, pain, sleep and physical activity were all associated with mental 
health outcomes. We hypothesized that moderate levels of these physical symptoms would be 
related to the presence of having mental health symptoms. This study will help inform the 
development of evidence-based interventions to treat the physical symptoms that contribute to 
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Chapter 1: Review of the Literature 
Cerebral palsy (CP) is the most prevalent childhood physical disability, affecting two 
children for every 1000 live births.(Oskoui et al., 2013; Van Naarden Braun et al., 2016) The 
disorder is complex due to the range of clinical signs and symptoms that vary from person to 
person, however, the primary impairments are in movement and posture.(Colver et al., 2014) In 
addition, CP is associated with co-occurring impairments that can have progressive effects on a 
seemingly non-progressive condition. Secondary conditions associated with CP include sleep 
disorders, cognitive and/or musculoskeletal dysfunction, epilepsy, and behavioural 
symptoms.(Novak et al., 2012) In particular, children and youth with CP are at higher risk of 
experiencing mental health symptoms than the general population.(Downs et al., 2018; 
Goodman, 1998) Untreated mental health symptoms can lead to a higher risk of developing 
depression and anxiety disorders that persist into adulthood.(Pine et al., 1998) Furthermore, 
untreated anxiety and depression can lead to significant academic, adaptive, and social 
difficulties, a decreased quality of life, and can have substantial economic burden on the 
healthcare system.(Sienko, 2018)  
Experiencing fatigue, pain and disruptions in sleep, are related to mental health outcomes 
for children with CP.(Van Der Slot et al., 2012; Whitney, Warschausky, et al., 2019) These 
evolving secondary impairments have significant consequences for individuals in this 
population.(Frisch & Msall, 2013) Conversely, the relation between physical activity (PA) and 
mental health has been less examined in CP; however, PA may have a positive impact on mental 
health such as increased cognitive performance, improvements in behaviour disturbances, and 
promote social behaviour.(Gapin et al., 2011; Menear & Neumeier, 2015) Literature suggests 
that these factors together may contribute to the experience of mental health symptoms and give 
clinicians and researchers an avenue by which they may intervene and provide treatment. People 
with disabilities or chronic health conditions may be as much as three to four times more likely 
to develop depression and anxiety disorders.(Sienko, 2018; Van Der Slot et al., 2012) This study 
will seek to examine the relation between mental health symptoms in children and youth with CP 
and physiological risk factors and PA. It is hypothesized that children with CP who experience 
fatigue, pain, and disordered sleep will experience increased mental health symptoms of 
depression and anxiety.(Baxter, 2013; Helseth et al., 2016; Lindsay, 2016) In addition, it is 





mental health, and could be employed as a protective intervention.(Keawutan et al., 2018) By 
identifying modifiable physiological factors that may contribute to the development of 
psychological symptoms in youth with CP, targets become available for intervention to improve 
the lives of children with CP and their families. CP is a lifelong disability, and thus secondary 
conditions experienced by individuals without targeted interventions would likely be experienced 
across the lifespan. Mental health interventions specifically tailored for children with CP are 
rare, and as such, there may be opportunities to change mental health experiences through 
addressing the physiological conditions, such as those that are being investigated here.  
Mental Health 
Like CP, mental health disorders are complex pathophysiological diseases with 
heterogeneous etiology. Mental health symptoms for children and adolescents include feelings of 
stress, anxiety and depression in their day to day lives.(Lindsay, 2016) Experiencing mental 
health symptoms is sometimes a preliminary sign of developing a more serious condition or a 
mental illness. Mental illness or a mental disorder can be diagnosed when preliminary symptoms 
become more severe, chronic, or increase in frequency. These psychological disturbances can 
progress into psychiatric diagnoses if left untreated. Results from the United States of America’s 
National Comorbidity Survey Replication -Adolescent Supplement (NCS-A) in 2010 showed 
that approximately 25% of all youth met criteria for a mental health disorder, with severe 
impairment across their lifetime.(Merikangas et al., 2010) Their rates suggested that most mental 
health disorders emerged before, and persisted into, adulthood where incidence of mental health 
increases with age.(Lewinsohn et al., 1998) Cross sectional data has shown that rates of mental 
health symptoms double from 13 to 14 (8.4%) years to 17 to 18 (15.4%) years.(Merikangas et 
al., 2010) Mood disorders were the most commonly occurring mental disorder, specifically 
anxiety-related disorders.(Merikangas et al., 2010) While this statement encompasses mental 
health prevalence at large, children with disabilities, including CP, are at a higher risk of 
experiencing mental health symptoms compared to their peers.(Whitney, Warschausky, et al., 
2019) Children with CP tend to experience more emotional and behavioural symptoms including 
depression, anxiety and attention problems compared to their siblings without CP.(Levy-Zaks et 
al., 2014) In a longitudinal retrospective study, Smith et al., (2019), found that individuals with 
CP had an increased risk of being diagnosed with depression or anxiety, compared to a matched 





concluded that 57% of their sample of children with CP met criteria for a psychiatric 
disorder.(Bjorgaas et al., 2012) Youth with CP may be at increased risk in part due to the 
presence of physiological health conditions (fatigue, pain, disordered sleep, etc.) that can impact 
mental health more so than their peers.(van Gorp et al., 2019) People with CP experience many 
physiological, psychological, social and health related risk factors that have been shown to be 
associated with depression and anxiety such as pain(Jahnsen et al., 2004), functional 
limitations(Odding et al., 2006), difficulties in social relationships(Cacioppo et al., 2006) and 
poor sleep.(Tremblay et al., 2011) Mental health and wellness can be affected by chronic pain, 
social difficulties and loss of independence, all of which are experienced by children with 
CP.(Krigger, 2006) To further compound the issue, external mental health resources are costly 
and availability of such resources are scarce. Although individuals with CP experience more 
anxiety and depression compared to their peers, it is not yet known why, or which combination 
of factors contribute most to poorer mental health outcomes. 
Depression and Anxiety in CP 
 Major depressive disorder (MDD) is categorized by a combination of symptoms 
including low mood, loss of affect, and loss of interest. Depressive disorders are commonly 
found to be linked to fatigue and pain in the general population.(Trivedi, 2004) Whitney et al., 
(2020) found pain, fatigue, and sleep disorders further increased the likelihood of a mood 
disorder in a population of young and middle-aged adults with CP.(Whitney et al., 2020) 
Pediatric MDD is often left untreated and undiagnosed with only 50% of adolescents diagnosed 
being treated for their psychological symptoms prior to adulthood.(Kessler et al., 2001) In the 
general population, implications for later in life diagnoses and delay in treatment is associated 
with poorer health outcomes including worsening of mental health status, development of other 
mental disorders and an increased risk of suicide.(Kisely et al., 2006) Prolonged and untreated 
mental illness can have costly effects on healthcare and social service systems. It is estimated 
that the cumulative cost of providing treatment, care, and support services over the next 30 years 
in Canada is expected to exceed $2.5 trillion in current dollars.(Smetanin et al., 2011) There is 
ample and increasing evidence that investing in the right programs can contribute to helping the 
prevention of mental illnesses, delaying their onset, and reducing associated ill health and 





address mental health-related symptoms as soon as they develop to limit progression to mental 
illness and maximize overall health and well-being. 
Behavioural Disorders in CP 
In addition to mental health symptoms that are prevalent in this population, behavioural 
difficulties can also be present, which can impact children’s relationships and interactions. One 
in four children with CP have behavioural difficulties.(Horwood et al., 2019b) A study by Parkes 
et al., (2008) determined that 95% of parents reported that their children with CP had 
behavioural problems that lasted over a year and 37% said that these problems caused their child 
distress.(Parkes et al., 2008) These children often have difficulties with relationships, attention 
problems, hyperactive behaviour and exhibit antisocial characteristics including isolation, being 
disobedient and having troubled relationships with their peers.(McDermott et al., 1996) These 
behavioural characteristics are more often associated with psychological impairments 
(Sigurdardottir et al., 2010) and are significant to note as peer interactions and the development 
of relationships are vital at a young age to develop social skills required in adolescence and 
adulthood. The same study by Parkes et al., (2008) also determined that a significant proportion 
of participants that had psychological symptoms that were severe enough to warrant intervention, 
with over 40% of their sample scoring in the borderline to abnormal range on the Strengths and 
Difficulties Questionnaire.(Parkes et al., 2008) Further evidence of the impact of behavioural 
challenges comes from a study by Whitney et al., (2019), where children that had a harder time 
making friendships were found to have a higher prevalence of psychiatric conditions. In addition, 
there was an elevated presence of behaviour and conduct problems in children who experienced 
bullying.(Whitney, Peterson, et al., 2019)  
Physiological Risk Factors and CP 
Secondary conditions including fatigue, pain, and sleep disturbances, can have worsening 
effects on the motor disorders of CP which may increase the possibility of experiencing mental 
health symptoms or disorders. Although physiological risk factors can impact all levels of motor 
disturbances, physical health status is lower in children and youth that are less ambulatory than 
their peers.(Jacobson et al., 2020) 
Fatigue 
Fatigue is a common secondary condition associated with CP.  Fatigue may be 





activities of daily living.(Brunton & Bartlett, 2017) Interestingly, in a study conducted by van 
der Slot et al., (2012), fatigue severity was associated with depressive symptoms in adults with 
CP. Chronic pain and severe fatigue co-occurred in 34% of participants and further in 
combination with depressive symptoms in 16% of participants.(Van Der Slot et al., 2012) In a 
thematic qualitative synthesis by Lindsay et al., (2016), researchers collated themes that were 
classified according to the International Classification of Functioning, Disability, and Health - 
Child and Youth Framework and found that many of the studies included in the review suggested 
youth with CP often experience pain, fatigue and other physical or physiological impairments to 
body structure and function, which affect the ability to cope and participate in leisure and 
recreation activities.(Lindsay, 2016) Brunton et al., (2019) described the main contributors to 
fatigue for youth and young adults with CP including activity-related tasks, general demands of 
life, sleep, mental health concerns and environmental concerns.(Brunton et al., 2019) The 
authors suggested that many of these factors are modifiable and may be targeted by an 
intervention, however, further research is needed to determine if these factors are indeed 
modifiable in this population. The fatigue presentation appears to be relatively stable within 
adults with CP over time across all functional ability (Gross Motor Function Classification 
System (GMFCS)) levels.(Oude Lansink et al., 2018) Fatigue scores in the Oude Lansink et al., 
(2018) study did not change over a three-year follow up period, indicating that adults who 
experience fatigue are likely to remain fatigued without intervention.(Oude Lansink et al., 2018) 
In a study by McPhee et al., (2017), researchers examined the experience of fatigue in adults 
with CP, inclusive of all five GMFCS levels, and if PA, sedentary time and body mass index 
levels (BMI) could predict fatigue outcomes in this population. Using the Fatigue Impact and 
Severity Self-Assessment (FISSA), McPhee et al., (2017) determined a significant and positive 
association between BMI and fatigue scores indicating that participants with higher BMI levels 
had increased fatigue. In addition, they found a significant negative relation between MVPA per 
hour and FISSA scores, suggesting that physical activity intensity may be a potential target for 
mitigating losses in function in this population.(McPhee et al., 2017) Brunton (2018) determined 
that the overall effect of fatigue is greater for participants with more functional 
limitations.(Brunton, 2018; Brunton & Bartlett, 2017) In addition, there were non-significant 





although fatigue may be overly present in this population, there are few fatigue-focused 
interventions available for people with CP.(Brunton, 2018) 
Chronic Pain 
Pain is a common secondary condition associated with CP and is often experienced in 
childhood and may become a chronic impairment throughout adulthood. Acute pain becomes 
chronic if it persists after three months or beyond the expected time for healing and is an 
increasingly common concern for children and adolescents with disabilities.(Massaro et al., 
2013) Children with CP are at risk for chronic pain due to a combination of surgical, 
orthopaedic, gastrointestinal and/or rehabilitative experiences.(McKearnan et al., 2004) The 
prevalence of pain in children in this population varies with estimates ranging from 20% to 
65%.(Houlihan et al., 2008) Common contributors to pain can include hip subluxation, muscle 
spasms, dystonia and constipation.(Penner et al., 2013) Recurrent musculoskeletal pain is the 
most prevalent pain experienced by children and adolescents with CP and becomes more 
prevalent with age.(Ramstad et al., 2011) Specifically in CP, overuse of muscles or strains 
caused by involuntary movements, atypical joint position and the imbalance of muscle use are all 
factors related to the experience of pain.(Jahnsen et al., 2004) Chronic pain in children can lead 
to broader impairments in a child’s functioning including to their mobility, interpersonal 
interactions, physical and psychosocial functioning as well as restrict their school 
participation.(Palermo, 2000)  
In a study by Penner et al., (2013), researchers concluded that 25% of children with CP 
experienced moderate to severe pain which affected their ability to participate in 
activities.(Penner et al., 2013) Pain has also been shown to negatively affect mental health and 
quality of life for children with CP and their families.(Findlay et al., 2016; Ramstad et al., 2012) 
Pain becomes more prevalent with age, but is not correlated to a specific type, or severity of CP 
and may contribute to additional functional impairments experienced by the individual.(Baxter, 
2013; Houlihan et al., 2008; Mckinnon et al., 2019) 
Disordered Sleep 
Sleep allows for important biological processes to occur including restoration to memory, 
cognition and learning.(Verschuren et al., 2016) In a study by Noel et al., (2018), researchers 
determined that sleep mediated the association between post-traumatic stress symptoms and pain 





percent of children with CP were determined to have a significant pathological sleep disorder 
score compared to only five percent of children in the general population.(Newman et al., 2007) 
Both biological and environmental factors contribute to the increased frequency of sleep 
disorders in children with CP.(Mindell et al., 2006) Sleep disturbances often experienced by 
children with CP include initiating and maintaining sleep, sleep and wake transitions, sleep 
breathing disorders, nightmares and sleep talking.(Newman et al., 2007) Sleep deficiency is an 
outcome of disordered sleep and can increase the risk of negative mood, behavioural problems, 
cognitive impairments, poor school performance and metabolic disturbances.(Dutt et al., 2015) 
Furthermore, sleep has also been shown to be strongly associated with behavioural difficulties in 
children with CP.(Horwood et al., 2019b) There is also a strong bidirectional relationship 
between pain and sleep, which can reduce sleep quality in children and youth with CP. Factors 
including skin breakdown, pressure ulcers, involuntary movements and abnormal muscle 
postures can increase the experience of pain during sleep.(Newman et al., 2007) Sleep may be a 
modifiable and quantifiable risk factor that should be considered when analyzing mental health 
symptoms or in an interventional study.  
The Importance and Impact of Physical Activity 
It is recommended that children and adolescents achieve at least 60 minutes of PA every 
day with diversified activities, including fitness, strength, coordination, and flexibility 
exercises.(Waltersson & Rodby-Bousquet, 2017) CP is mainly characterized by impairment in 
motor control, which depending on GMFCS level, can impact habitual physical activity levels. A 
systematic review by Keawutan et al., (2014) determined that higher habitual physical activity 
levels were associated with higher motor capacity in children with CP.(Keawutan et al., 2014) 
Children with CP are not as physically active as their peers and often participate in lower 
intensity PA.(Maher et al., 2007) This may produce a deconditioning of the muscular, skeletal, 
and cardiorespiratory systems which can contribute to a cycle that increases the disability level 
over time.(Maher et al., 2007) Using an accelerometer, a study by Ryan et al., (2015) determined 
that children with CP spent more time in sedentary behaviour and accumulated less time in total, 
moderate, vigorous PA and sustained MVPA than their typically developing peers.(Ryan et al., 
2015) In addition, low levels of PA have contributed to the development of chronic pain, fatigue 
and osteoporosis for people with CP.(Fowler et al., 2007) In an integrative review conducted by 





carry over into adulthood and provide benefits in physiological, emotional, cognitive and social 
domains, however this needs to be investigated further.(Koldoff & Holtzclaw, 2015; Martin, 
2013)  
Physical Activity as a Potential Therapeutic Target 
Participating in daily PA provides benefits across a number of different health domains. 
A systematic review by Warburton and Bredin (2017) demonstrated a dose-response relationship 
between PA and premature mortality, highlighting the power of PA for prevention of many 
chronic medical conditions. The study depicts a curvilinear relationship whereby health benefits 
are observed with relatively minor, thus achievable, volumes of PA.(Warburton & Bredin, 2017) 
Children and youth that experience high PA and low sedentary behaviour also experienced 
health benefits(Saunders et al., 2016), for example, children with CP that engage in more PA 
behaviours exhibit lower systolic blood pressure than those that are more sedentary.(Ryan et al., 
2014) In addition, PA levels have also been shown to directly impact the secondary impairments 
associated with CP such as chronic pain(Hirsh et al., 2011) and fatigue(Nieuwenhuijsen et al., 
2011) and perhaps PA can be used as a treatment option for this population to reduce the impact 
of these comorbid impairments.  
Physical Activity and Mental Health 
Increased PA frequency and intensity is associated with decreased depressive symptoms 
in children and adolescents generally.(Korczak et al., 2017) Conversely, decreased PA and 
increased sedentary behaviour can vulnerably dispose children to developing depressive 
symptoms.(Sund et al., 2011) PA interventions are becoming more widely used in mental health 
research, specifically for treating affective symptoms including depression and anxiety, as well 
as and behavioural symptoms including inattention and oppositional defiant behaviours.  
Children with CP are more sedentary and engage in less PA related behaviours than their 
peers due to the motor limitations associated with the disorder.(Lauruschkus et al., 2013) In 
addition, the energy expenditure that these children experience while standing or moving with or 
without support is elevated significantly.(Verschuren et al., 2014) Increased energy expenditure 
can lead to higher physical strain which may contribute to early onset fatigue in children with 
CP.(Dallmeijer & Brehm, 2011; Maltais et al., 2005) PA interventions have been shown to be 
successful in reducing fatigue severity and increasing health-related quality of life with respect to 





Lauruschkus et al., (2017) indicated that a PA intervention was feasible and effective for children 
with CP to promote participation, motivation and engagement in physical activities to limit 
sedentary behaviours.(Lauruschkus et al., 2017)  
Physical Activity in Mental Health Interventions 
Evidence based interventions for children and youth with depression include cognitive 
coping methods, problem solving strategies, activity scheduling, and social skill 
building.(Wissow et al., 2016) Mental health interventions have not yet been adapted and 
validated for youth who experience other physiological risk factors including fatigue, pain and 
sleep disturbances. However, these factors are thought to be modifiable and could be the target 
of interventions to increase the quality of life and address the mental health symptoms 
experienced by children with CP. Identifying modifiable physiological risk factors that play a 
role in mental health is vital for early intervention in childhood and adolescence and to limit the 
persistence of symptoms into adulthood where they may be confounded by age-related changes 
to the motor disorder. PA may be an avenue for treatment of these factors and may have the 
ability to relieve or lessen some of these symptoms. Reducing sedentary activity by integrating 
PA into the daily routine of people with CP may also contribute to functional independence and 
enhance the quality of life of these individuals.(Rimmer, 1999)  
Purpose 
The purpose of this study was to observe physiological factors (including fatigue, pain, 
disordered sleep), and PA and their combined association with mental health symptoms in 
children with CP. Many children and youth experience these physiological symptoms in tandem, 
and they may have a combined effect on mental health symptoms. Mental health symptoms 
considered for the purpose of this study included internalizing and externalizing behaviours, 
depression and anxiety. The combined effects of these elements have not been assessed in 
relation to PA. In addition, this research has yet to be conducted in a pediatric population, as 
most of the research regarding physiological risk factors and mental health was conducted with 
adult populations. It is imperative to determine the associations between these factors to better 
understand the course of mental health in CP. This study aims to examine the associations 
between PA, symptoms of fatigue, pain, sleep disturbances and determine their impact on mental 





Chapter 2: Methods 
Ethical Approval and COVID-19 Amendments 
This study is a part of a larger study examining associations between physiological 
factors and mental health in children and youth with CP. This study was approved by the Health 
Sciences Research Ethics Board at Western University and by the Conjoint Health Research 
Ethics Board at the University of Calgary (Appendix A). All participants and/ or parents 
provided informed consent to participate in the study (Appendix B). Due to recent events 
associated with the COVID-19 pandemic, the data collection methods were amended as per 
Western University regulations. The study was able to be conducted completely remotely, and 
even allowed for recruitment of some participants and their families that resided in rural 
communities, which would not have been possible with the planned data collection methods 
prior to COVID-19.  
Design 
This cross-sectional observation study examined the contribution of secondary risk and 
protective factors to mental health outcomes using online surveys and accelerometers. This 
exploratory research is part of a larger study that examines mental health and collected measures 
beyond what is included in this analysis. Data was collected from September 2019 to August 
2021.  
Participants with CP and/or one of their caregivers completed a variety of standardized 
assessment measures, and caregiver/self-report questionnaires to assess symptoms of anxiety and 
depression and secondary physiological risk factors. All questionnaire data collection was 
collected via online survey platforms. Using the platforms REDCap, Q-Global and MHS 
Measurements, a link was provided via email to parents to fill out the questionnaires. Following 
the online questionnaires participants wore two accelerometers (ActiGraph GT9X Link; wrist 
and waist) to document sleep and PA data for 7 days and nights. It has been recognized that 
attachment sites of the Actigraph can influence counts per minute between wrist and waist bound 
sites.(Hjorth et al., 2012; Loprinzi & Smith, 2017) Actigraphy sites were thereby distinguished 









 It was hypothesized that all physiological factors (fatigue, pain and sleep disturbances) 
and PA would contribute to the variance observed in the mental health measures (both child and 
parent report).  
Participants 
Inclusion Criteria 
 Children and youth with CP ages 8 to 18 years, with any level of functional ability (as 
measured by the GMFCS) were recruited with parental consent and/or assent by convenience 
sampling from a variety of Calgary, AB and/or London, ON health and community institutions. 
This age range was chosen for two purposes, 1) based on the validity and availability of the 
measures for this population and 2) to address the onset and course of mental health symptoms 
prior to adolescence and through the transition to adulthood. To participate, children had to 
communicate using verbal language. Children with CP with other medical conditions including 
medication-controlled epilepsy, an intellectual disability, among others, were able to participate 
in the current study.  
Exclusion Criteria 
Children with disorders other than CP were not eligible for the study including those with 
epilepsy (without a CP diagnosis), traumatic brain injury, neurofibromatosis, or any autoimmune 
disorders. Children with these disorders were excluded due to the differing etiology of disorders 
compared to CP. Children/youth that were not able to communicate verbally were also deemed 
ineligible for the study due to the nature of collecting data.  
Measures 
Functional Ability Level  
Functional ability level was assessed by the GMFCS. Due to the remote data collection 
methods of the study, GMFCS level was provided by caregiver knowledge. The GMFCS is a 
reliable and valid five-level scale that classifies a child’s gross motor function with an emphasis 
on movement initiation, sitting control, and walking.(Bodkin et al., 2003; Palisano et al., 1997) 
Level I represents the highest gross motor function, whereas level V represents the 
lowest.(Bodkin et al., 2003) CP is a heterogeneous condition with multiple causes, clinical types, 





preferred, however due to the variability across multiple domains in this population, functional 
ability level was used to describe the sample. 
Mental Health: Anxiety and Depression  
To measure symptoms of anxiety and depression, both parent and child completed the 
Behaviour Assessment System for Children, Third Edition (BASC-3)(Altmann et al., 2017), the 
Child Depression Inventory (CDI)(Kovacs, 2015), and the Multidimensional Anxiety Scale for 
Children, Second Edition (MASC-2)(March, 2000). For all mental health measures, T scores 
were used in the analysis. Raw scores are not comparable between children since they may have 
a different number of items between scales depending on the type of report (i.e. self-report vs 
parent-report). To facilitate interpretation of the results, raw scores were converted into T scores, 
or standardized scores. T scores for these measures use age and sex-based norms to determine 
how one participant’s score compares to others that are the same age and same sex to enhance 
interpretation. 
The BASC-3 assesses emotional disorders, personality constructs, and behavioural 
problems in children and adolescents and has shown good validity compared to other similar 
measures.(Burback, 2020; Kamphaus, 2015; Merenda, 1996) Internalizing behaviours are 
defined as inwardly directed distress which are indicative of a child’s emotional state, while 
externalizing behaviours are those behaviours presented outwardly and are observed by the 
child’s behaviour in their environment.(Liu et al., 2011) Higher scores on the BASC-3 indicates 
higher incidence of internalizing problems. Average T scores are between 41 and 59 (range 
within which two thirds of the general population will score), while clinically relevant scores 
vary between from 0 to 30 and 70 and above.(Altmann et al., 2017) For the purpose of this study, 
the internalizing behaviour T score from child self-reported scales was used as a dependent 
mental health symptom variable. 
The CDI is a brief self-report test that helps assess cognitive, affective and behavioural 
signs of depression in children and adolescents. The CDI has been shown to have high internal 
validity.(Finch et al., 1987; Helsel & Matson, 1984; Smucker et al., 1986) Higher scores on the 
CDI (both child and parent report) indicate more marked or definite symptoms of depression. T 
scores that fall below 60 indicate average item endorsements for the child’s age and sex. Scores 
60 to 64 fall into the high average category while scores greater than 70 would endorse multiple 





of this study, the total T score for child and parent reports was used as a dependent mental health 
outcome variable.  
Finally, the MASC-2 is a reliable and valid, 39-item assessment that collects anxiety 
related data across 4 domains (physical symptoms, social anxiety, harm avoidance and separation 
anxiety).(March et al., 1997) Higher scores on the MASC-2 indicate more marked or definite 
symptoms of anxiety. T scores between 40 and 54 indicate typical level of concern and are 
deemed within “Average” range. Scores 55-59 indicate a “High Average” range that causes 
borderline concern. Scores between 60 and 64 indicate slightly elevated and indicate more 
concerns than are typically reported. Scores greater than 70 are deemed very elevated and a 
significant cause for concern.(March, 2000) For the purpose of this study, the T score will be 
used as the dependent outcome variable for both child and parent reports. Together these 
measures will provide good insight to mental health impacts in this population. 
Fatigue 
Fatigue was measured by the Fatigue Impact and Severity Self-Assessment (FISSA), see 
Appendix C. The FISSA has been shown to have adequate test-retest reliability and is a valid 
measure of fatigue for individuals with CP.(Brunton & Bartlett, 2017) The FISSA is a 37-item 
measure that provides a preliminary description of activities that fatigue interferes with, an 
overview of the severity of fatigue experienced by the individual and the specific management 
strategies used by an individual.(Brunton & Bartlett, 2017) Responses to the first 31 items 
provide a total score (ranging from 31 to 157) and higher scores indicate higher fatigue. The 
remaining six questions are qualitative in nature and are not included in the total score.(Brunton 
& Bartlett, 2017) The Total FISSA, Impact and Severity Subscale, and Activity Modification and 
Management Subscale Scores were considered as physiological predictor variables in the data 
analyses. 
Pain 
Self-reported pain was measured by the Youth Pain Questionnaire, see Appendix D. The 
Youth Pain Questionnaire is a reliable and valid measure designed to assess functional 
impairment due to chronic pain in school-age children.(Noel et al., 2016) The variables of most 





Objective Movement Data 
Using an accelerometer to record movement is both non-invasive and objective.(Ancoli-
Israel et al., 2015; Cellini et al., 2013) An accelerometer can capture raw activity volume in 
structured activities of increasing intensity including sitting, walking and jogging. Although 
there is no gold standard device for measuring objective movement data, the ActiGraph and 
ActiLife software have been used extensively for measuring PA and sleep data in populations 
with CP, which allows for comparability of results. Furthermore, ActiGraph accelerometers have 
been validated to be feasible and unobtrusive for participants with all GMFCS levels.(Capio et 
al., 2010; Clanchy et al., 2011; Gorter et al., 2012)  
Accelerometer instructions and logs were distributed to each family via Canada Post 
mailing, see Appendix E. Participants were asked to wear their ActiGraphs for 24 hours for 7 
days. However, if participants did not wear the ActiGraphs for 7 days, their data was still used.  
Participants mailed their accelerometers back to their local PI where a cleaning/disinfecting 
procedure was implemented. Local PIs wore medical grade gloves and used Lysol disinfectant to 
wipe down each accelerometer and a solution with Lysol and water was used to clean the fabric 
straps used to secure the accelerometer prior to uploading the data. Each accelerometer was 
cleaned a second time, again with the PI wearing gloves, before being sent to the next 
participant. Each instruction package included a link to an instructional video and daily logs (see 
Appendix E), to capture sleep and rise times and device removal. 
Sleep  
Accelerometers worn on the wrist have been previously determined to be both valid and 
reliable for measuring sleep and wake periods in 60-second epochs in young adults and 
children.(Cellini et al., 2013; Taylor et al., 2015) To objectively measure movement data, 
participants were asked to wear one accelerometer (Actigraph GT9X Link) around their wrist to 
capture sleep data. Scoring of wrist activity provides useful information about sleep and 
wakefulness that can be applied in clinical and research applications.(Cole et al., 1992) Wrist 
actigraphy, worn on the non-dominant hand, has been validated and deemed reliable to collect 
sleep information.(Weiss et al., 2010) In addition, the accelerometer data was used to estimate 
the prevalence of sleep disturbances including sleep efficiency, wake after sleep onset (WASO) 
and number of awakenings. WASO is described by the number of minutes children are awake 





were determined from the daily average of sleep data collection per participant and were 
considered physiological predictor variables in the analyses. 
Physical Activity 
To measure PA, participants were asked to wear an accelerometer around their waist and 
on their hip, for the duration of the 7 days. PA has been validated with monitor placement on the 
waist to assess whole-body movement.(Hjorth et al., 2012; Knaier et al., 2019) Waist actigraphy 
during activities of daily living has been validated and has high interrater reliability.(Migueles et 
al., 2017; Ozemek et al., 2014) Accelerometers were used to explore three variables including 
step count, % of time spent sedentary and % of time spent in MVPA. The ActiGraphs were 
initialized with a sample rate of 30 Hz. A 60 second epoch, across three axes, were used for data 
analysis. Using the Choi (2011) algorithm, wear and non-wear periods were determined and 
manually cross examined against log data.(Choi et al., 2011) Variables were extracted using the 
ActiLife software by applying the following algorithms, Freedson VM3 for energy expenditure, 
Freedson Children (2005) for metabolic equivalent of task and Evenson Children (2008) for cut 
points and MVPA.(ActiGraph Software Department, 2012) These algorithms were chosen for 
their sensitivity and validity for this population.(Clanchy et al., 2011; Trost et al., 2011) These 
variables were collected each day over the 7 day wear period and a daily average was calculated. 
Standard Canadian PA guidelines indicate that children and youth should participate in a 
minimum of 60 minutes of moderate to vigorous PA per day and limit sedentary 
behaviours.(Canadian Society for Exercise Physiology, 2011) In addition, children and 
adolescents with cerebral palsy are encouraged to engage in the same physical activity 
behaviours as their typically developing peers.(Verschuren et al., 2016) The Canadian Physical 
Activity Guidelines for children and youth ages 5 to 17 years were used to calculate a proportion 
of the sample that were meeting versus not meeting these guidelines.  
Statistical Analyses 
All statistical analyses were performed using the Statistical Package for the Social Sciences 
(SPSS, IBM) Version 27. Descriptive statistics including mean, standard deviation, median and 
range, as appropriate, were used to describe demographic characteristics of the sample. Pearson’s 
correlation coefficients were used to assess which physiological predictor variables were most 
highly correlated with the dependent mental health outcomes to determine which physiological 





outcomes. A series of separate backwards stepwise multiple linear regressions were used to 
examine the associations between physiological variables and mental health outcomes of 
internalizing behaviours, depression and anxiety parent and child reports. A backwards deletion 
approach for the regression allows for all the independent variables to be entered into the 
regression and each is deleted if it does not provide unique contribution to the regression 
equation once the other variables are accounted for. This method reduces the number of predictor 
variables and reduces the issue of multicollinearity. Due to the small sample size and missing 
data, a pairwise case deletion method was used to include as much of the data as possible. Linear 
regressions were performed with each mental health measure, BASC-3 child, CDI child and 
parent, MASC-2 child and parent as the dependent variable. The assumptions of linear regression 
were tested using as follows:  
 
 Variable Types: All predictor variables were set as quantitative or categorical and 
specifically the outcome variable was quantitative, continuous and descriptive statistics 
were used to determine if it was unbounded.  
▪ Non-zero variance: Variance of predictor variables was determined through examining 
standard deviation of scores.  
▪ No perfect multicollinearity: Incidence of multicollinearity indicates that there is an 
occurrence of high correlation between independent variables found in the regression. 
Multicollinearity was tested during the linear regression using the variance inflation 
factor (VIF). VIF values that are between 1 and 10 indicate no multicollinearity and 
values that are <1 or > 10 indicate multicollinearity.(Field, 2009) 
▪ Homoscedasticity: Indicates that at each level, the predictor variables should be 
constant. Homoscedasticity was examined by visually interpreting the scatter plot where 
the residuals are equal across the regression line. Scatter plots were plotted with the axes 
ZRESID; the standardized residual (Y-axis) and *ZPRED; the standardized predicted 
values of the dependent variable based on the regression model (X-axis). 
▪ Independent Errors: The Durbin-Watson Test was used to check whether the residuals 
in the model were independent. The Durbin-Watson test will always have a value 





the sample. Values less than 2 indicate positive autocorrelation and values greater than 2 
indicate negative autocorrelation.(Field, 2009) 
▪ Normally Distributed Errors: It was assumed that the residuals in each model are 
random and normally distributed, with a mean of 0. This assumption was tested by 
examining the histogram and normal probability plot with axes, ZRESID; the 
standardized residuals, or errors (Y-axis) and *ZPRED; the standardized predicted values 
of the dependent variable based on the regression model (X-axis). Points were assessed 
based on their location to the definite line. 
▪ Linearity: Mean values of the outcome variable for each increment of the predictors lie 
along a straight line. Scatterplots of the dependent and independent variables were 
created to examine if the relationships were linear in nature. Non-linear relationships 
limit the generalizability of the findings. 
Chapter 3: Results 
Demographics of study participants are presented in Table 1. In this sample, the mean age 
was 11.8 years (SD=2.9) and 87.5% of children were ambulatory based on GMFCS criteria 


















Table 1  
Demographic Factors 
 n=26  
Age,  Mean† (SD) 11.8 years  (2.9) 
Sex†, n, (%) 
       Male 
       Female 









Functional Ability Level‡ (GMFCS), n, (%) 
        I 
        II 
        III 
        IV 
        V 
     
                       11 










Ethnic Group†, n, (%) 
       White 
       East Asian 
       Hispanic 
       Indigenous  
       Black  















Parent 1 Highest Level of Education, n, (%) 
      High School 
      Some Post-Secondary 
      Completed Post-Secondary 
      Masters 
      PhD 















Parent 2 Highest Level of Education, n, (%) 
      High School 
      Some Post-Secondary 
      Completed Post-Secondary 
      Masters 













Average Annual Household Income† n, (%) 
      Prefer not to say 
      $35,000 to $49,999 
      $50,000 to $74,999 
      $75,000 to $99,999 














†= Missing data for 4 participants 
‡= Missing data for 6 participants 
 






Physiological Risk Factor Scores 
Physiological Risk Factors   
Fatigue ‡, Mean (SD) 
     Total Score 
     Impact & Severity 









Pain Duration, n‡ (Valid %) 
      Less than 1 hour 
      A few hours 
      Half of the day 











Pain Impact, n‡ (Valid %) 
      Not at all 
      A little 
      Between a little and a lot 
      A lot 













Pain Severity‡, Median (Range) 3.5 (8) 
Sleep, Mean‡ (SD) 
      WASO 
      Efficiency (%) 









Physical Activity, Daily Mean§ (SD) 
     Step Count 
     Minutes Spent in MVPA 
     % in MVPA 











Proportion of participants meeting 






‡= Missing data for 6 participants 
§= Missing data for 9 participants 
 
Note. WASO= Sleep After Wake Onset, MVPA= Moderate to Vigorous Physical Activity 
 
 
Mental Health Profiles  
Descriptive information for scores on the mental health measures are presented in Table 
3. Cut point information and frequencies for all mental health measures are reported in Tables 4-
7. The BASC-3 parent measure was intended to be included in the analysis; however, due to a 





were able to complete the full measure once the error was corrected. Therefore, the decision was 
made to exclude the parent report due to significant missing data. The mean internalizing score 
for the BASC-3 child report was 51.32 (SD=9.20). Based on T score information, BASC-3 Child 
scores for this sample were considered average. Mean child and parent CDI scores were 53.72 
(SD=13.06) and 58.81 (SD=11.29) respectively. Based on this criterion, mean CDI scores 
reported by both parent and child were within the normal range, with the parent's score reaching 
the “High Average” range. Mean MASC-2 scores were 52.95 (SD=12.35) and 60.93 (SD=13.79) 
for child and parent report respectively. Based on this sample, MASC-2 T scores based on child 
reports were in typical range (40-54) for their age. However, based on the parent report, T scores 
indicated a mean score that is slightly elevated (60-64) indicating slightly more concerns than 
would be expected for children this age.   
Table 3 
Mental Health Measure Scores 
 
Mental Health Measures  Score Type  Mean (SD) 
BASC-3 Child ** Internalizing T 51.3 (9.2) 
CDI Child ø Total T 53.7 (13.1) 
CDI Parent ¥ Total T 58.8 (11.3) 
MASC-2 Child * Total T 52.9 (12.3) 
MASC-2 Parent ¥ Total T 60.4 (13.8) 
 
¥= Missing data for 3 participants 
ø= Missing data for 5 participants 
*= Missing data for 10 participants 
**= Missing data for 11 participants 
 
Note. BASC-3= Behavioural Assessment System for Children 3rd Edition, CDI= Children’s 












BASC-3 Cut Points and Sample Frequencies 
Classification    




Very High Clinically Significant 70 and above 2 10.5% 
High At Risk 60-69 2 10.5% 
Average Average 41-59 15 79% 
At Risk Low 31-40 - - 
Clinically Significant Very Low 30 and below - - 
 
Note. BASC-3= Behavioural Assessment System for Children 3rd Edition 
Table 5 
CDI Cut Points and Sample Frequencies 










Very Elevated 70+ 4 16 5 18.5% 
Elevated 66-70 1 4 1 3.7% 
High Average 60-65 2 8 7 25.9% 
Average <60 18 72 14 51.9% 
      











MASC-2 Cut Points and Sample Frequencies 










Very Elevated 70+ 2 10% 6 22% 
Elevated 65-69 3 15% 3 11% 
Slightly Elevated 60-64 1 5% 6 22% 
High Average 55-59 2 10% - - 
Average 40-54 9 45% 12 44% 
Low <40 3 15% - - 
      
Note. MASC-2= Multidimensional Anxiety Scale for Children 2nd Edition      
Correlations 
See Tables 7-10 for the Pearson’s correlation coefficient data for each predictor/outcome 
variable pair. All hypothesized predictor variables (fatigue total score, fatigue impact and 
severity subscale, fatigue activity modification and management subscale, pain severity, pain 
impact, pain duration, sleep efficiency, WASO score, number of awakenings, % time in MVPA, 
% in time in sedentary activity and step count) were assessed and those with the most significant 
correlations across mental health outcomes were chosen for each hypothesized predictor 
grouping (Fatigue, Pain, Sleep, PA). However, judgments were made regarding sleep and fatigue 
variables where the sleep efficiency score contains WASO and the total fatigue score contains 
the subscales. Based on these factors and considering correlations across all mental health 
measures, the following variables were included: 
▪ Fatigue Total Score 
▪ Pain Severity 
▪ Sleep Efficiency (%) 
▪ % time in MVPA 























.165 .114 .084 -.017 .035 
Sig. (2-tailed) .442 .596 .697 .943 .892 







.193 .004 .073 -.063 -.121 
Sig. (2-tailed) .366 .986 .735 .799 .632 






.104 .222 .082 .042 .229 
Sig. (2-tailed) .629 .297 .703 .864 .361 
N 24 24 24 19 18 
 
**. Correlation is significant at the 0.01 level (2 tailed). 
*. Correlation is significant at the 0.05 level (2- tailed). 
 
Note. CDI= Children’s Depression Inventory, MASC-2= Multidimensional Anxiety Scale for 


































Pearson Correlation .226 .033 -.182 -.230 .065 
Sig. (2-tailed) .288 .878 .396 .344 .799 
N 24 24 24 19 18 
Pain 
Severity 
Pearson Correlation -.030 -.266 -.342 -.426 -.502* 
Sig. (2-tailed) .888 .208 .102 .069 .034 
N 24 24 24 19 18 
Pain 
Impact 
Pearson Correlation .196 -.173 -.232 -.264 -.296 
Sig. (2-tailed) .359 .420 .276 .275 .233 
N 24 24 24 19 18 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
Note. CDI= Children’s Depression Inventory, MASC-2= Multidimensional Anxiety Scale for 























-.158 -.195 -.038 -.255 -.243 
Sig. (2-tailed) .460 .384 .862 .324 .331 





.129 .433* .039 .189 .344 
Sig. (2-tailed) .549 .044 .858 .467 .162 






-.077 .255 -.186 -.017 .089 
Sig. (2-tailed) .721 .253 .385 .947 .725 
N 24 22 24 17 18 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Note. CDI= Children’s Depression Inventory, MASC-2= Multidimensional Anxiety Scale for 





























.345 .373 .462* .328 .493* 
Sig. (2-tailed) .126 .116 .035 .233 .044 






.478* .287 .363 .215 .649** 
Sig. (2-tailed) .028 .234 .106 .442 .005 






-.267 -.081 -.606** -.190 -.376 
Sig. (2-tailed) .242 .741 .004 .497 .137 
N 21 19 21 15 17 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
Note. CDI= Children’s Depression Inventory, MASC-2= Multidimensional Anxiety Scale for 
Children 2nd Edition, BASC-3= Behavioural Assessment System for Children 3rd Edition, 
MVPA= Moderate to Vigorous Physical Activity 
 
Assumptions of Linear Regression 
Tests for the assumptions of linear regression determined the following: 
▪ Variable Types: All predictor variables were demonstrated to be quantitative or 
categorical and the outcome variables were unbounded.  
▪ Non-zero variance: Standard deviation, range and minimum and maximum values 
demonstrated non-zero variance for all predictor variables.  
▪ No perfect multicollinearity: Results from tests of multi-collinearity are indicated in 
Table 11. VIF values are between 1 and 10 for all predictors, thus, predictors were not 
highly correlated with each other. The average VIF score is close to 1, confirming that 





▪ Homoscedasticity: Based on the scatterplots of the standardized residuals and 
standardized predicted values, the histogram and normal probability plots there was no 
evidence of heteroscedasticity in the data.  
▪ Independent Errors: The Durbin-Watson Test for all regression models were between 
1.5 to 2.5, demonstrating minimal autocorrelation in the sample. 
▪ Normally Distributed Errors: The scatter plots produced demonstrated a random array 
of dots evenly dispersed around zero confirming normally distributed errors.  
▪ Linearity: Scatterplots of the data revealed linear relationships between predictor 
variables and the outcome variables for those predictors that were significant or remained 



















































Pain Severity .791 1.263 
Sleep Efficiency .765 1.307 
% in MVPA .584 1.713 
% in Sedentary .499 2.004 
Fatigue .821 1.218 
 
2 
Pain Severity .812 1.231 
Sleep Efficiency .889 1.125 
% in MVPA .894 1.119 
Fatigue .821 1.218 
3 Pain Severity .826 1.211 
% in MVPA .979 1.022 
Fatigue .830 1.204 













Pain Severity .791 1.263 
Sleep Efficiency .765 1.307 
% in MVPA .584 1.713 
% in Sedentary .499 2.004 
Fatigue .821 1.218 
 
2 
Pain Severity .792 1.263 
Sleep Efficiency .765 1.307 
% in Sedentary .764 1.309 
Fatigue .823 1.214 
 
3 
Pain Severity .817 1.224 
% in Sedentary .973 1.028 
Fatigue .833 1.201 
4 Pain Severity .973 1.028 
 % in Sedentary .973 1.028 
5 % in Sedentary 1.000 1.000 
 
Note. CDI= Children’s Depression Inventory, MASC-2= Multidimensional Anxiety Scale for 
Children 2nd Edition, BASC-3= Behavioural Assessment System for Children 3rd Edition, 










Five hierarchical regressions were conducted, one for each mental health outcome (child 
and/or parent report) the BASC-3 (Child), CDI-2 (Child and Parent), and MASC-2 (Child and 
Parent).   
Regression 1: BASC-3 
Using the backward stepwise linear regression approach with the BASC-3 child-report 
internalizing T score as the dependent variable, three models were found to be significant. 
Significant regression equations include: 
 
Model 1: (F(5, 11)= 5.88, p<0.007), with an adjusted R2 of 0.60. Participants predicted mental 
health was equal to 58.69 - 2.43 (Pain Severity) - 0.35 (Sleep Efficiency) +4.48 (% time in 
MVPA) + 0.231 (% time in Sedentary) + 0.10 (FISSA Total Score), where pain severity was 
coded on a scale from 0 (no pain) to 10 (very much), sleep efficiency was measured as a percent, 
% time in MVPA and % time in Sedentary were measured as percent of total wear time spent in 
each activity category and Total Fatigue Score was measured on a scale ranging from 31-157.  
Model 2: (F(4, 12)= 7.06, p<0.004), with an adjusted R2 of 0.60. Participants mental health was 
equal to 66.64 -2.31 (Pain Severity) -0.23 (Sleep Efficiency) +3.68 (% in MVPA) +0.1 (FISSA 
Total Score), where pain severity was coded on a scale from 0 (no pain) to 10 (very much), sleep 
efficiency was measured by percent, % in MVPA was measured as percent of total wear time in 
spent in moderate to vigorous activity and Total Fatigue was measured on a scale ranging from 
31-157.  
Model 3: (F(3, 13)= 9.50, p<0.001), with an adjusted R2 of 0.61. Participants mental health was 
equal to 45.00 -2.24 (Pain Severity) + 3.93 (% in MVPA) +0.11 (FISSA Total Score), where 
pain severity was coded on a scale from 0 (no pain) to 10 (very much), % in MVPA was 
measured as a percent of total wear time spent in moderate to vigorous activity and FISSA Total 
Score was measured on a scale ranging from 31-157.  
 
Models of Significance 
Table 12 visually presents the possible models that were found to be significant. All three 
significant models were similar in their R2 and adjusted R2; however, Model 3 was deemed to be 





measure of variance explained. The R2 and adjusted R2 values indicate the proportion of variance 
in the outcome variable that is explained by the predictor variables, with the adjusted R2 
accounting for the number of predictors in the model. The predictor variables that remained in 
Model 3 included Total Fatigue, Pain Severity and % time in MVPA and combined explained 


















% time in 
MVPA 







1 0.85 0.73 0.60   ✔ ✔ ✔ ✔ ✔ 
2 0.84 0.70 0.60   ✔ ✔ ✔ - ✔ 
3 0.83 0.69 0.61* ✔ - ✔ - ✔ 





1 0.74 0.54 0.39   ✔ ✔ ✔ ✔ ✔ 
2 0.74 0.54 0.41* ✔ ✔ - ✔ ✔ 
3 0.70 0.49 0.39   ✔ - - ✔ ✔ 
4 0.65 0.43 0.36   ✔ - - ✔ - 
5 0.61 0.37 0.33   - - - ✔ - 
 
*= Most significant regression model for the dependent mental health variable. 
 
Note. MVPA = Moderate to Vigorous Physical Activity, BASC-3 = Behaviour Assessment System for Children, 3rd Edition, CDI = 






Regression 2: CDI Child 
For the CDI-Child, six models were tested for the association between CDI as the 
dependent variable and the predictor variables above; no significant regression models were 
found. Based on this information, depression outcomes from child reports could not be modelled. 
 
Regression 3: CDI Parent 
Using the backward stepwise linear regression to predict depression based on parent 
reports from the predictor variables, one model was determined to be significant. The only 
predictor variable that remained in the model was % time in MVPA with an adjusted R2 value of 
0.18. The significant regression equation is as follows: 
 
Model 5: (F(1, 17)= 5.04, p<0.038), with an adjusted R2 of 0.18. Participants’ depression 
reported by parent report was equal to 53.61 + 3.77 (% time in MVPA), where % time in MVPA 
was measured as percent of total wear time spent in moderate to vigorous physical activity. 
Mental health increased 3.77 points on the Parent CDI for each additional percent of time spent 
in MVPA.  
 
Regression 4: MASC-2 Child 
For the MASC-2 Child report, six models were tested for the relationship between 
MASC-2 as the dependent variable and the predictor variables, no significant regression models 
were found. Based on this information, anxiety outcomes from child reports could not be 
modelled. 
 
Regression 5: MASC-2 Parent 
Using a backward stepwise linear regression to predict parent-reported child anxiety 
related behaviours using the physiological predictor variables produced five significant models. 
Significant regression equations include: 
 
Model 1: (F(5, 13)= 3.10, p<0.046), with an R2 of 0.54. Participants anxiety based on parental 





0.67 (sleep efficiency) + 0.15 (FISSA Total score ), where pain severity was coded on a scale 
from 0 (no pain) to 10 (very much), % time in Sedentary and % time in MVPA were measured as 
percent of total wear time spent in each activity category, sleep efficiency was measured as a 
percent, and FISSA Total Score was measured on a scale ranging from 31-157.  
Model 2: (F(4, 14)= 4.16, p<0.02), with an R2 of 0.54. Participants anxiety based on parental 
report was equal to 78.43  -1.94 (pain severity) -1.04 (% time in sedentary) +0.67 (sleep 
efficiency) +0.15 (FISSA Total score), where pain severity was coded on a scale from 0 (no 
pain) to 10 (very much), % in Sedentary was measured as a percent of total wear time spent in 
sedentary activity, sleep efficiency was measured by percent, and FISSA Total Score was 
measured on a scale ranging from 31-157. 
Model 3: (F(3, 15)= 4.90, p<0.01), with an R2 of 0.49. Participants anxiety based on parental 
report was equal to 126.13 -2.21 (pain severity) - 0.87 (% time in sedentary) + 0.14 (FISSA Total 
Score), where pain severity was coded on a scale from 0 (no pain) to 10 very much), % in 
Sedentary was measured as a percent of total wear time spent in sedentary activity and FISSA 
Total Score was measured on a scale ranging from 31-157. 
Model 4: (F(2, 16)= 5.98, p<0.01), with an R2 of 0.43. Participant's anxiety was based on 
parental report is equal to 133.86 - 1.51 (pain severity) - 0.86 (% in sedentary), where pain 
severity was coded on a scale from 0 (no pain) to (10 very much), % in Sedentary was measured 
by percent of total wear time spent in sedentary activity.  
Model 5: (F(1, 17)= 9.86, p<0.006), with an R2 of 0.37. Participant's mental health was equal to 
133.74 - 0.92 (% in Sedentary), where % in Sedentary was measured as a percent of total wear 
time spent in the sedentary activity.  
 
Models of Significance 
Table 12 visually represents the possible models that were found to be significant. All 
five of the five models proposed demonstrated significance, and had similar proportions of 
variance explained; however, Model 2 showed the best fit due to the smallest difference between 
R2 and adjusted R2 values as a conservative measure. and the highest adjusted R2 to account for 
the number of predictors in the model. The predictor variables that remained in Model 2 included 
Pain Severity, Sleep Efficiency (%), % time in Sedentary, FISSA Total Score and explained 41% 






 A power analysis was conducted using the sample size of 26 participants and the BASC-3 
Child regression model. The power to detect a significant model was 0.29 based on 5 predictors. 
The study was underpowered to predict significant models based on the sample size of 26 
participants. Based on the variance explained in the regression models and the power of 0.80, a 
sample size of 78 would be required to be fully powered. 
Chapter 4: Discussion 
The principal finding of this investigation is that physiological risk factors in part, 
contribute to overall mental health symptoms for children with CP. Based on the significant 
regression models, various combinations of the physiological variables were able to predict 
mental health symptoms in the sample. Across all outcomes and models, pain severity was the 
most common predictor retained in the models, followed by % time spent in sedentary activity, 
FISSA total score, % time spent in MVPA and sleep efficiency respectively. Evidence from the 
literature suggests that these physiological risk factors and PA are highly inter-correlated, which 
could explain the different combinations of statistically significant predictors; however, they 
were not so highly correlated that they did not offer unique contributions to mental health 
symptoms.  
Physiological Risk Factors and Physical Activity 
 Results from physiological risk factor data indicate that children and youth with CP 
experience significant fatigue, pain and sleep disturbances. Furthermore, children and youth with 
CP experience lower levels of PA compared to the recommended PA levels established in the 
Canadian Physical Activity Guidelines for Children and Youth.(Canadian Society for Exercise 
Physiology, 2011) Fatigue scores from this sample indicate that children and youth are 
experiencing fatigue throughout the day; however, mean FISSA scores were lower in this sample 
than reports of older youth and adults with CP.(Brunton & Bartlett, 2017; McPhee et al., 2017) 
The variability in fatigue scores (as assessed by the standard deviation) was significant, 
indicating that there are some participants experiencing more fatigue than others within the 
sample. Although there are no clinical cut points for the FISSA, these scores indicate that the 
current sample experiences mild to moderate levels of fatigue daily, based on maximum and 





current sample, with some participants experiencing little pain and others experiencing moderate 
to high pain levels. Pain severity was most predictive across all regression models, this may 
indicate that although the average pain level was not considered severe, the pain experience still 
contributed to the experience of mental health symptoms. The pain levels reported by Brunton et 
al., (2016) in their sample of youth and adolescents with CP were similar (3/10 for males, 6/10 
for females).(Brunton et al., 2016) Sleep efficiency scores in this sample were similar to 
typically developing children(Borghese et al., 2018) and contradictory to the literature that 
indicates that sleep disturbances are common in CP populations.(Romeo et al., 2014; van Gorp et 
al., 2019) Incidentally, sleep efficiency was the least predictive of all the physiological risk 
factors, and fell out most often from significant regression models, potentially indicating that the 
method of determining sleep efficiency is not accurately representing any CP-specific sleep 
disturbances children may experience. Physical activity in this sample was very low compared to 
Canadian guidelines which suggest children should limit the time they spend sedentary and 
engage in at least 60 minutes of MVPA per day. MVPA for this sample was one third of the 
recommended guidelines. Based on results from this sample, children and youth with CP spent 
almost 80% of their day sedentary and less than 2% in MVPA. The variability in PA scores were 
limited, indicating that most children in this sample are getting similar amounts of PA per week. 
This is in accordance with previous literature where Ryan et al., (2015) determined that children 
with CP spent more time in sedentary behaviour and accumulated less time spent in MVPA than 
their typically developing peers (Ryan et al., 2015) and potentially limited the ability to assess 
PA as a protective factor for experiencing mental health symptoms.  
 
Internalizing Behaviours 
Table 4 describes cut points and frequencies for the BASC-3. The mean T score for 
internalizing behaviours in this sample for the child report fell within the average clinical range, 
yet physiological risk factors were able to predict levels of internalizing behaviours T score 
levels. Average scores on the BASC-3 may indicate that behavioural issues or emotional 
irregularities may be present to a degree, and associated with physiological risk factors. 
Interestingly, in accordance with the wide spread of the data, standard deviations indicated that 
there were scores within the at-risk range for internalizing behaviours, despite the mean T score 





personality constructs in children and adolescents. Based on the results from the significant 
BASC-3 Child regression model, pain severity, FISSA total score and % time in MVPA best 
predicted the internalizing scores of children with CP. From the three statistically significant 
models, Model 3 was most representative of the general population given that its adjusted R2 
value was closest to 1, where 1 indicates that the regression predictions perfectly fit the data. 
However, Models 1 and 2 both had similar R2  and adjusted R2 values. A higher adjusted R2  
value indicates that the new term improves the model more than what would be expected by 
chance. The R2 value for Model 1 suggests that 73% of the variance for child behavioural 
outcomes in this sample, is explained by the physiological risk factors. More interesting still, 
Model 1 included all of the predictor variables, compared to Model 3 which included only total 
fatigue, pain severity and % time in MVPA. Since Model 1 and 3 are similar in R2 and in 
adjusted R2, perhaps the predictors that fell out of the model (i.e. sleep efficiency and % time 
spent in sedentary activity) still contribute to overall mental health outcomes or could contribute 
more if outcomes were outside the average range, or with different levels of these predictor 
variables. In addition, there could be many factors driving this fit for the regression model. Due 
to a small sample size, covariates such as GMFCS level, sex and intelligence were not assessed 
and could have influenced the results. A study with a larger sample size could verify this 
association.  
These findings are in line with other research where Yamaguchi et al., (2014) determined 
that pain variables (pain intensity and pain anxiety) made significant contributions to predicting 
mental health outcomes including behavioural and emotional outcomes in children with 
CP.(Yamaguchi et al., 2014) Persistence of psychological and emotional problems in CP are 
associated with attentional difficulties and social interaction problems and often persist into 
adulthood.(Weber et al., 2016) The chronicity of CP means that these issues will ultimately 
impact them for the rest of their lives. Identifying associated risk factors can mitigate these 
problems later in life and can provide consistent support in alleviating these modifiable 
symptoms.  
Mood and Depression Symptoms 
Table 5 describes the cut points and frequencies for the CDI for both parent and child 
reports. T scores from the CDI-Child and Parent reports were within typical levels of item 





literature, where people with CP have a higher risk of developing depression compared to 
typically developing adults (Smith et al., 2019), and that chronic pain, fatigue, and prevalence of 
depressive symptoms were higher in adults with CP than healthy controls.(Van Der Slot et al., 
2012)  However, mean age for this sample was 11.8 years (SD= 2.9), perhaps symptoms of 
depression become more evident and have greater impact with age, which might also explain the 
lack of significant regression models for the CDI-Child. In addition, based on the variability 
observed in individual data, some child reports fell within the “Elevated” range compared to 
average scores which would trigger cause for concern from the assessor. Furthermore, some 
individual parental reports indicated that their children were classified in the “Very Elevated” 
range, meaning multiple depression symptoms and functional impairment were endorsed. 
Research conducted in populations of adults with CP indicate higher depression levels, but little 
research has been conducted in the pediatric samples. Additional research around the time of 
transition from childhood to adulthood needs to be explored to determine when depression 
symptoms may be most apparent. Finally, evidence suggests that depression outcomes based on 
child reports could not be modelled with the predictors examined in this study. This is an 
interesting finding that might indicate there is a disconnect between parent and child reports, 
given the significant results found for the parent reports.  
Parental reports of child depression were predicted by a single significant model with a 
single predictor, % time in MVPA accounting for only 18% of the variance. This suggests that 
greater than 80% of the variance associated with mood related mental health for this population 
is related to unknown predictors. The small amount of variance explained combined with the 
inability to use physiological factors to predict CDI-child T scores implies that there may be 
other physiological factors or predictors that are better suited at predicting CDI T scores in this 
population that need to be explored. In a study by Asano et al., (2020) severity of self-reported 
depressive symptoms were higher in children with CP compared to their typically developing 
peers. These symptoms were mediated by hyperactivity and peer problems.(Asano et al., 2020)  
Therefore, other predictors to explore in future studies may include social aspects such as peer 
relationships, coping strategies, meaningful participation or more positive physiological factors 
such as assistive technology use given that the mood-based scores fell within the typical range 
for this sample. Additionally, this the conflicting evidence may be due to the small sample size 





the contributions of the variables assessed. Based on these models and findings from other 
significant mental health predictor models in the current study, the most unknowns related to 
mental health outcomes for this sample rest within the mood/depression outcomes. Given that 
CDI T scores for both child and parental reports were within the normal range, symptoms of 
depression may not be evident in this sample, perhaps alluding to why physiological risk factors 
did not significantly contribute to the models beyond % time spent in MVPA in the parent 
reports. This may indicate that PA could play a small protective role, when depression-related 
health symptoms are not evident or not clinically significant. In children with CP, happiness and 
quality of life are associated with higher levels of PA.(Kwon et al., 2020) A study by Maher et 
al., (2016) determined that PA significantly predicted physical and social quality of life and 
happiness.(Maher et al., 2016) Exercise training programs have also been found to have 
significant positive impacts on quality of life in motor, autonomy, and cognitive 
domains.(Verschuren et al., 2007) Since the majority of our sample (87.5%) is ambulatory 
(GMFCS levels I-III), findings of protective effects of PA could be made apparent. In addition, 
being physically active in adolescence doubled the probability of maintaining PA in adulthood in 
people with CP.(Waltersson & Rodby-Bousquet, 2017) Clinicians are increasingly aware of the 
physical and health benefits of PA and findings from recent literature and the current study may 
have positive implications on well-being in children with CP. Interventions that are aimed at 
increasing PA from youth to adulthood are likely to see lasting positive effects, however, future 
research should continue to assess mood-related outcomes and account for covariates including 
GMFCS, intellectual capability, age and sex. 
Anxiety Symptoms 
 Table 7 describes the cut points and frequencies for the parent and child reported 
MASC-2 T scores. The T scores for the MASC-2 child report were within the average range 
based on the MASC-2 manual criteria. Variability within the child reports do indicate that some 
T scores fell within the “Elevated” range, indicating more concerns than are typically reported. 
However, the mean T score from parental reports fell within two criteria above the average level 
into the slightly elevated category, and some participants fell within the “Very Elevated” range, 
the highest in the MASC-2 criteria, indicating many more concerns than are typically reported. 
There is a clear disconnect between child and parent reports for this specific measure. Baldwin et 





Australian sample (Baldwin & Dadds, 2007) and similar findings were found by Wei et al., 
(2014), where despite good internal reliability across subscales, the MASC displayed low 
agreement between child and parent reports.(Wei et al., 2014) This information creates 
uncertainty in terms of which report is more accurate to describe the mental health of the child. It 
is possible that the parent report is a more accurate representation as a result of the ability to 
predict five significant models for the outcome, while the MASC-2 child reports were 
inconclusive. There could also be child-specific factors that were not measured in the current 
study that should be considered in future research to determine accuracy of reporting from both 
groups. 
Based on regression results for the MASC-2 parent reports, five significant models 
accounted for at least 30% of the variation in scores. Model 2 had the highest adjusted R2 value 
where 41% of the variance was accounted for by pain severity, sleep efficiency, % time in 
sedentary and total FISSA score. Model 1 had the second highest adjusted R2 value at 0.39, 
where all of the physiological risk factors predicted parental reports of anxiety in children with 
CP. Similar to the predictive outcomes from the BASC-3, the adjusted R2 values were similar 
across the models and there was not a clear model that predicts significantly more of the variance 
for that mental health outcome. This is important to note when examining anxiety outcomes in 
this population, all physiological risk factors played a significant role and may warrant 
intervention or monitoring in clinical practice. 
Literature suggests that sleep efficiency was correlated with mental health outcomes in 
children with CP. A study by Romeo et al., (2014) indicates that a moderate correlation was 
found between the sleep total score and Child Behaviour Checklist scores.(Romeo et al., 2014) 
This finding aligns with this study since MASC-2 T scores from parent reports indicate slightly 
elevated anxiety levels. Anxiety is highly prevalent in CP and should be addressed accordingly 
in childhood. MASC-2 parental reports predicted five significant models for outcomes in anxiety 
in children with CP. It is important to keep these other models in mind when interpreting the 
results. 
For child measures of both depression (CDI) and anxiety (MASC-2) there is a gap in the 
understanding of these complex outcomes. Certainly, there are other factors that can predict 
mental health that have not been included in this model. Perhaps, to a child, there are more 





and emotional networks.(Majnemer et al., 2010; Shikako-Thomas et al., 2013) It is clear that 
factors including social participation, independence, bullying, acceptance are all important 
factors that can have a meaningful impact on a child’s life. Whitney et al., (2019) determined 
that social factors including difficulty with friendships, bully victimization, and lower 
participation were all associated with a higher prevalence of mental health disorders in children 
with CP.(Whitney, Peterson, et al., 2019) Children may perceive their mental health differently 
than their parents, and thus the role that these other factors play may be more influential in 
predicting child reported mental health outcomes. This may help explain the discrepancy 
between the parental and child reports on the CDI and MASC-2 in this study.  
Synthesis 
Evidence from the literature suggests that these predictors of mental health are associated 
with each other. Interestingly, no multicollinearity was found. Incidence of fatigue and pain are 
closely related, as are sleep and fatigue, and physical activity and pain. In children with physical 
disabilities, high levels of fatigue are associated with inactivity.(Maher et al., 2015) Fatigue and 
pain are known to be strongly associated and have significant impacts in this population.(van 
Gorp et al., 2019) Sleep, GMFCS classification, presence of comorbidity, pain and behavioural 
difficulties have been shown to be inter-correlated for children with CP.(Horwood et al., 2019a, 
2019b) These results mirror findings from this study where different physiological risk factors 
can have significant impact on children’s mental health outcomes. Given that the 
multicollinearity assessment was within acceptable range for each of the independent variables, 
this infers an association between mental health and each risk factor. Furthermore, as a result of 
these complex relationships between physiological factors, it is difficult to determine a single 
physiological risk factor that significantly contributes the most to modeling mental health. 
Therefore, all factors may warrant continued assessment, monitoring and clinical intervention as 
they may be contributing, in different amounts or at different times, to the overall quality of life 
in children with CP. Sienko et al., (2014) reported that many of the young adults participating in 
their study reported depression with some attempting suicide, only a small percentage indicated 
they were receiving appropriate treatment.(Sienko, 2014) Assessment and treatment of these 
symptoms before they escalate an important clinical finding may have protective mental health 





Strengths and Limitations 
This is the first study to systematically examine the associations between fatigue, pain, 
sleep disturbances, PA and mental health symptoms in children with CP. Previous literature has 
documented associations between risk factors, or contributions of sole risk factors on mental 
health outcomes, however, the results documented here are imperative to the field as they begin 
to unravel the complex nature of associations between risk factors as predictors of mental health 
outcomes. Statistical modeling determined that all physiological factors examined in the current 
investigation play some role in the mental health of persons with CP and that it is vital for 
clinicians and families to understand these factors to better understand their lives. However, 
there are limitations to this study that affect the implementation of the findings. Firstly, because 
of the cross-sectional research design, causality or directionality in association between 
exposures and outcomes was unable to be determined. Causation can be determined through 
covariation, temporal precedence and controlling for other variables and should be explored in 
future work. Additionally, the correlations documented in this study demonstrate value in 
conducting future longitudinal studies. Secondly, due to the COVID-19 pandemic, the sample 
size for this study was smaller than expected due to delayed recruitment and challenges 
associated with data collection and the study was underpowered. With a larger sample size, it is 
expected that more variability in the mental health outcomes and the predictor variables would 
contribute to increased power to model the associations presented here. Also, in part due to the 
remote nature of the study and other external factors, there were several missing data points 
across participants that resulted in an overall smaller sample size that could be used for analysis 
at this time point. As a result of the small sample size, the decision was made not adjust for 
covariates including intelligence, GMFCS level, age and sex. However, the T scores that were 
collected for the mental health measures determine how one score may compare to others of the 
same age and sex. In this case, we were not able to control for these covariates but by comparing 
to a normative sample, we were able to consider the findings at the individual level. Future 
research should consider these and other covariates explicitly in models of mental health 
outcomes. In addition, there are certainly other factors that contribute to the overall state of 
mental health in children with CP. Social risk factors, parental stress and burden have also been 
shown to be associated with adverse child mental health outcomes but were beyond the scope of 





for use with children with CP. Only the CDI has been validated and deemed reliable for children 
with physical disabilities including those with CP.(de la Vega et al., 2016) However, the BASC-
3 and MASC-2 have been demonstrated to be reliable and valid for children and adolescents 
including with disabilities including adolescents with Down Syndrome for the BASC-3 (Jacola et 
al., 2014) and youth with learning disabilities for the MASC-2.(Thaler et al., 2010) Additionally, 
recruitment and data collection for this study took place during the COVID-19 pandemic, and it 
should be recognized that mental health data may be elevated during this time therefore results 
should be interpreted with caution and confirmatory studies should be conducted in the future to 
validate these findings. Furthermore, the COVID-19 pandemic could have influenced PA levels 
due to restrictions and the inability to participate in PA at school and in the community. Finally, 
the majority of the data was collected the winter months in Canada which could have impacted 
PA rates as children are less likely to be active during these times. 
 Clinical Implications and Future Directions 
It is anticipated that this research will aid clinicians and scientists in better understanding 
the course of CP and assist with educating patients, families and other healthcare providers about 
the potential impacts physiological factors can have on a child’s mental health status. Clinicians 
should recognize the importance and screen for these physiological risk factors if their clients are 
demonstrating concerning symptoms of poor mental health. Conversely, clinicians should 
consider monitoring mental health or referring to a mental health specialist when presence or 
impact of physiological symptoms are high. Results from the current study contributes to 
increased transparency about the natural course of CP and highlight the need for early 
identification of these risk factors. Early identification can be beneficial for this population later 
in life by introducing helpful interventions that can mitigate morbidity long-term and particularly 
around the time of transition from adolescence to adulthood where self-advocacy, identification 
of challenges and self-management become much more important. Determining the modifiable 
physiological risk factors that can impact mental health and wellbeing for children with CP is the 
first step in optimizing their quality of life through clinical monitoring, and the development of 
interventions and/or preventative measures to reduce the burden associated with CP for these 
children and their families. Examples of modifiable risk factor interventions can include self-





Future research in this area is required to accurately distinguish causality between 
physiological risk factors, PA and mental health symptoms in this population. Mental health 
interventions are not readily accessible for children and youth with CP and have not been 
tailored to their specific needs. Results from this study present the opportunity and knowledge 
needed to design and test novel interventions specifically intended for this population to address 
the complex associations between known predictive physiological factors and mental health 
outcomes. Combining effective treatments for single physiological factors into a multi-modal 
intervention may be beneficial for clinicians and their families. Multi-modal interventions can be 
time and economically efficient while still addressing mental health concerns by reducing the 
contribution associated with these predictors. 
Conclusion 
Fatigue, pain, sleep disturbances and PA all significantly affect mental health symptoms 
in children with CP even if the specific outcomes are not clinically concerning. Pain severity, 
sleep efficiency, percentage of spent in MVPA and in sedentary activity, and fatigue were all 
represented in the significant regression models. This research highlights the importance of 
creating and evaluating mental health and physiological risk factor interventions that can 
optimize quality of life for children with CP.  Further longitudinal research is encouraged to 
determine directionality between these risk factors and mental health symptoms. Finally, targeted 
research should be conducted at or around the transition stages of adolescence to early adulthood 
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Informed Consent Forms 
Assent Form 
 
TITLE:  Anxiety and Depression in Youth with Cerebral Palsy:                                         
Role of Physiological Risk Factors 
 
SPONSOR:  Hotchkiss Brain Institute (HBI) 
3330 Hospital Dr NW 
Calgary, AB T2N 4N1 
 
INVESTIGATORS: Carly McMorris, PhD1, Laura Brunton, PhD2, Melanie Noel, PhD1, Daniel 
Kopola Sibley, PhD1, Elizabeth Condliffe, PhD1, Benjamin Fong, MSW2, 
Stephanie Howe1, Mica Pabia1, Kate Hall1 
   1University of Calgary, Werklund School of Education 
   2 Alberta Health Services (AHS)      
 
Local PI: Dr. Laura Brunton 
 
You are being invited to be in a research study help us learn from you and your experience with 
cerebral palsy related to mental health, fatigue, pain and physical activity. 
 
Why are we doing this study? 
We would like to figure out whether the things that you feel in your body, such as how much 
sleep you are getting, how tired you feel during the day, and whether you feel any pain in your 
body, affects the way that you feel in your brain (for example your emotions and the way you 
think about things). 
 
What will happen during the study? 
If you are o.k. with participating in this study, we will mail you what you will need to do. The 
first things are two Actigraphs. Actigraphs are small devices that will give us information about 
your physical activity during the day and about how much sleep you are getting every night. 
You will get one to wear around your waist and one to wear around your wrist. You will wear 
both for 7 days and 7 nights 
 
The second thing will be some questions that you will answer every day about how you are 
feeling in your body. These will ask how tired you felt, how well you slept, and how much pain 
you felt that day. Once you receive your Actigraph in the mail we will send you the daily surveys 
to fill out. These will be sent to you through email and you will be able to complete them 
online.  
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We will also email you some things to do online. Online questionnaires will ask you questions 
about your mood, things that you do, how well you sleep, and whether you feel any pain in 
your body. Your parent will be asked the same types of questions about you. We will also call 
you to ask you some more questions about how you feel, think, and behave. We will talk to you 
either on the phone or over video chat. All of this will take about 3 hours of your time. 
 
Are there good things about the study? 
Most kids like doing the activities that we will ask you to do. The things that we learn from 
doing this study will be used to help other kids with cerebral palsy. 
 
Are there bad things about the study? 
Sometimes kids may get bored or tired when they are doing the activities. You may ask to take 
a break whenever you need to. Most kids are ok with wearing the Actigraphs and it does not 
bother them at all but some kids may find it uncomfortable to wear the Actigraph for a long 
time. We will make sure that the things we mail to you are extra clean so that you don’t get 
sick. If you really don’t want to wear the Actigraph, you don’t have to do that part of the study. 
 
Who will know about what I say or do in the study? 
If you are part of this study, we won’t tell people outside of the research team about what you 
said or did or how you answered your questionnaires. We may want to write papers about 
what we learned from doing this study, but these papers won’t include your name or 
information that could let people know that you were a part of this study. If we are worried 
about your safety, or if we think that you could use help with something that we are not able to 
help you with, we may ask your mom or dad if we can contact your doctor or psychologist and 
let them know. We will destroy any papers that we used in this study or any of your information 
once the study is done. We will be sending your parents a summary of how you did on the 
different tasks.  
 
Can I decide if I want to be in the study? 
You can decide if you want to be in the study. It is O.K. if you do not want to be part of the 
study. It is O.K. if you say yes now and change your mind later. Your parents know about the 
study and have said that you can be in it. You can ask questions any time that you want. If you 
decide you do not want to be in the study we will not keep any of your information. 
 
Assent: 
The study has been explained to me. I know that I can ask questions about the study at any 
time. I know that I can stop at any time. I have been told that all of the information collected 
will not be given to anyone. Your parents and the research team will only see the information 
collected. 
 
If you have any questions about the information here, you can ask your mom or dad for help, or 
you can contact the researchers and we can help explain it to you.  
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If you understand everything that was explained to you here, and are ok with participating in 
the study, please click on the button that says, “I am ok with participating in this study” 
 
    I am ok with participating in this study 
 I do not want to participate in this study 
  
 
Parental Surrogate Consent 
 
TITLE:  Anxiety and Depression in Youth with Cerebral Palsy:                                         
Role of Physiological Risk Factors 
 
SPONSOR:  Hotchkiss Brain Institute (HBI) 
 
INVESTIGATORS: Carly McMorris, PhD1, Laura Brunton, PhD2, Melanie Noel, PhD1, Daniel 
Kopola-Sibley, PhD1, Elizabeth Condliffe, PhD1, Benjamin Fong, MSW2, 
Stephanie Howe1, Mica Pabia1, Kate Hall1 
   1University of Calgary, Werklund School of Education 
   2 Alberta Health Services (AHS)      
 
 
CONSENT FORM:  Caregiver Consent for Child to Participate  
 
This consent form is only part of the process of informed consent. It should give 
you the basic idea of what the research is about and what your participation will 
involve. If you would like more detail about something, please ask. Take the time 




Anxiety and depression are very common in kids and teens with cerebral palsy (CP), affecting 
about 57%. It is unknown why anxiety and depression develop and continue in this population. 
Importantly, existing mental health treatments haven’t been adapted for kids with CP and 
mental health concerns. Untreated anxiety and depression in these kids and teens can lead to 
difficulties in many areas of life at home and at school. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
The purpose of this study is to identify physical risk factors that may lead to the development of 
anxiety and depression in kids with CP. This will be the first study to look at the relationship 
between physical symptoms (pain, low energy levels, and trouble sleeping) and anxiety and 
depression in kids with CP. Findings from this study will help identify risk factors that we can 
treat, and improve the lives of this vulnerable population. 
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WHAT WOULD MY CHILD HAVE TO DO? 
Participation involves three parts: 1) a mental health interview, 2) online questionnaires, and 3) 
a 7-day assessment of your child’s physical health symptoms. 
 
1. Mental Health Interview: we will arrange a time with you and your child where we will call 
you either on the phone or on video chat. We will ask your child questions about their mental 
health symptoms, emotions, and behaviours. We will record the interview so that we can 
remember your child’s information correctly.   
 
2. Questionnaires: We will send questionnaires to your child’s (and/or your) email address for 
your child to complete. These questionnaires will ask about your child’s mental health, physical 
health, pain, energy levels, and sleep.   
 
3. Seven (7)-day assessment of physical health symptoms: Your child will receive a package with 
the materials they will need in the mail. We will ask your child to wear two Actigraphs at all 
times for 7 days and 7 nights: one on their waist, and one on their wrist. These Actigraphs are 
small devices that will record your child’s activity. The Actigraph will give us information about 
your child’s physical activity and how well they are sleeping. We will also ask your child to 
answer a few questions each day about their mood, sleep, pain, and energy levels for the 7 
days, through a short (5 minute) survey that we will send to them over email at the same time 
each day.   
 
WHAT ARE THE RISKS? 
All the parts of this study have been reviewed and there are minimal risks involved. 
 
• The only risk of your child completing the questionnaires is that they may become 
tired. For this reason, they may take breaks or stop at any time. They will be working 
on the questionnaires in their own time at home and will have up to two weeks to 
complete them. The questionnaires and the interview will take a total of about 3 
hours. 
• Some children (especially children with sensory sensitivities) may find wearing the 
Actigraphs uncomfortable. The Actigraphs should not cause any more discomfort 
than a regular belt or wristwatch. However, if your child finds wearing the Actigraph 
particularly uncomfortable, they may decline to participate in that portion of the 
study. 
• Some questions that we ask, your child may not feel comfortable answering. That is 
ok, and they may skip questions that they do not want to answer. 
• As we are currently experiencing a global pandemic, we have made adaptations to 
the study that allow us to collect information from you without any face-to-face 
contact. However, we will be sending a package to your home containing the 
Actigraph and we cannot guarantee that it is free from contamination. Our team will 
take extra care to sanitize these materials. If you and your child are interested in 
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taking part in the study, but would rather wait until risks associated with the 
coronavirus have lowered, please let us know. We would be happy to save your 
contact information and contact you at a later date. You and your child  may also 
choose to do every part of the study, except for wearing the Actigraph if you would 
like.  
 
ARE THERE ANY BENEFITS? 
This study will be filling a gap in the current research by helping us find health behaviours that 
can be targeted with treatments that already exist. You will receive a report with information 
about your child’s performance on the measures we collect. You may choose to share this 
report with support services and schools. 
 
DOES MY CHILD HAVE TO PARTICIPATE? 
Whether you would like your child to participate in this study is your decision. You can 
withdraw your child at any time without it affecting your relationship with your healthcare 
providers. If any new information comes up that might affect your choice for your child to 
participate in the study, we will let you know as soon as possible. 
 
WILL MY CHILD BE PAID FOR PARTICIPATING, OR DO WE HAVE TO PAY FOR ANYTHING? 
Your family will receive a $50 gift card to compensate you for your time. You will not have to 
pay for anything; postage will be pre-paid. 
 
WILL MY CHILD’S RECORDS BE KEPT PRIVATE? 
We will keep any information about your child that we collect as confidential (private) as 
possible. We will store all information that we collect about your child in a locked filing cabinet. 
We will encrypt data and keep it in secured computer databases. We will use a number to 
identify your records rather than your name. 
 
We will keep a master list connecting your child’s name to your study ID number in a separate, 
secure location. We will keep your research records for at least seven years after the study has 
ended. We will limit access to your personal information to the researchers listed on the first 
page of this form. If we let other researchers use the information we have collected from this 
study, it will not contain your child’s personal information. We will not use your child’s name in 
any publication of the research results. 
 
If necessary, we may give reports related to this research to the University of Calgary Conjoint 
Health Research Ethics Board or the Western University Health Sciences Research Ethics Board. 
These organizations will treat such information with strict confidentially.  
 
If you decide to revoke this consent at any time and withdraw your child’s data from the study, 
we will destroy your child’s research data whenever possible. To revoke your consent, please 
speak to a member of the research team. 
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☐ I agree to be contacted about my child’s future participation in other research studies 




If you have any further questions or want clarification regarding this research and/or your 
child’s participation, please contact the Local Investigator, Dr. Laura Brunton. 
 
If you have any questions about your rights as a research participant or the conduct of the 
study, you may contact The Office of Research Ethics. 
 
A copy of this consent form has been given to you to keep for your records and reference. The 




Selecting the “I consent…” option below indicates that 1) you understand to your satisfaction 
the information provided to you about your child’s participation in this research project, and 2) 
you agree for your child to participate in the research project. 
In no way does this waive your legal rights nor release the investigators, sponsors, or involved 
institutions from their legal and professional responsibilities. You are free to withdraw your 
child from this research project at any time. You should feel free to ask for clarification or new 
information throughout your participation.  
 
 I consent for my child participate in this research study 
 I do not wish for my child to participate in this research study 
 
Adult Participant Consent 
 
TITLE:  Anxiety and Depression in Youth with Cerebral Palsy:                                         
Role of Physiological Risk Factors 
 
SPONSOR:  Hotchkiss Brain Institute (HBI) 
   3330 Hospital Dr NW 
Calgary, AB T2N 4N1 
 
 
INVESTIGATORS: Carly McMorris, PhD1, Laura Brunton, PhD2, Melanie Noel, PhD1, Daniel 
Kopola Sibley, PhD1, Elizabeth Condliffe, PhD1, Benjamin Fong, MSW2, 
Stephanie Howe1, Mica Pabia1, Kate Hall 1 
   1University of Calgary, Werklund School of Education 
   2 Alberta Health Services (AHS) 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Local PI: Dr. Laura Brunton 
 
CONSENT FORM:  Adult Participant Consent to Participate   
 
This consent form is only part of the process of informed consent. It should give 
you the basic idea of what the research is about and what your participation will 
involve. If you would like more detail about something, please ask. Take the time 




Anxiety and depression are very common in kids and teens with cerebral palsy (CP), affecting 
about 57%. It is unknown why anxiety and depression develop and continue in this population. 
Importantly, existing mental health treatments haven’t been adapted for kids with CP and 
mental health concerns. Untreated anxiety and depression in these kids and teens can lead to 
difficulties in many areas of life at home and at school. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
The purpose of this study is to identify physical risk factors that may lead to the development of 
anxiety and depression in kids with CP. This will be the first study to look at the relationship 
between physical symptoms (pain, low energy levels, and trouble sleeping) and anxiety and 
depression in kids with CP. Findings from this study will help identify risk factors that we can 
treat, and improve the lives of this vulnerable population. 
 
WHAT WOULD I HAVE TO DO? 
Participation involves three parts: 1) a mental health interview, 2) online questionnaires, and 3) 
a 7-day assessment of your physical health symptoms. 
 
1. Mental Health Interview: we will arrange a time with you where we will call you either 
on the phone or on video chat. We will be using the Zoom platform to complete the video chat 
calls. We will ask you questions about your mental health symptoms, emotions, and 
behaviours. We will record the interview so that we can remember your information correctly. 
Your parent will also be asked to answer the same questions about you separately. These video 
calls will be recorded for our research purposes for up to 7 years after your assessment.  
 
2. Questionnaires: We will send questionnaires to your (or your parent’s) email address. 
These questionnaires will ask about your mental health, physical health, pain, energy levels, 
and sleep. We will also ask your parent to fill out some questionnaires about you.  
 
3. Seven (7)-day assessment of physical health symptoms: You will receive a package with 
the materials you will need in the mail. We will ask you to wear two Actigraphs at all times for 
7 days and 7 nights: one on your waist, and one on your wrist. These Actigraphs are small 
devices that record your activity. The Actigraph will give us information about your physical 
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activity and how well you are sleeping. We will also ask you to answer a few questions each day 
about your mood, sleep, pain, and energy levels for the 7 days, through a short (5 minute) 
survey that we will send to your email at the same time each day.  
 
WHAT ARE THE RISKS? 
All the parts of this study have been reviewed and there are minimal risks involved. 
 
• The only risk of you completing the questionnaires is that you may become tired. For 
this reason, you may stop or take breaks at any time. You will be working on the 
questionnaires in your own time at home and will have up to two weeks to complete 
them. The questionnaires and the interview will take a total of about 3 hours. 
• Some participants (especially those with sensory sensitivities) may find wearing the 
Actigraphs uncomfortable. The Actigraphs should not cause any more discomfort than a 
regular belt or wristwatch. However, if you find wearing the Actigraph particularly 
uncomfortable, you may decline to participate in that portion of the study. 
• Some questions we ask, you may not feel comfortable answering. That is ok and you 
may skip questions if you would like. 
• As we are currently experiencing a global pandemic, we have made adaptations to the 
study that allow us to collect information from you without any face-to-face contact. 
However, we will be sending a package to your home containing the Actigraph and we 
cannot guarantee that it is free from contamination. Our team will take extra care to 
sanitize these materials. If you are interested in taking part in the study, but would 
rather wait until risks associated with the coronavirus have lowered, please let us know. 
We would be happy to save your contact information and contact you at a later date. 
You may also choose to do every part of the study, except for wearing the Actigraph if 
you would like.  
• There is always the possibility of a privacy breach with online data collection; however, 
we will use best practices including passwords, firewalls and limiting access to your data 
to only essential personnel to reduce this risk. 
 
ARE THERE ANY BENEFITS? 
This study will be filling a gap in the current research by helping us find health behaviours that 
can be targeted with treatments that already exist. You will receive a report with information 
about your performance on the measures we collect. 
 
DO I HAVE TO PARTICIPATE? 
Whether you would like to participate in this study is your decision. You can withdraw at any 
time without it affecting your relationship with your healthcare providers. If any new 
information comes up that might affect your choice to participate, we will let you know as soon 
as possible. 
 
WILL I BE PAID FOR PARTICIPATING, OR DO WE HAVE TO PAY FOR ANYTHING? 
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Following completion of the in-person assessment, your family will receive a $50 gift card to 
compensate you for your time. You will not have to pay for anything; postage will be pre-paid. 
 
WILL MY RECORDS BE KEPT PRIVATE? 
We will keep any information about you that we collect as confidential (private) as possible. We 
will store all information that we collect about you in a locked filing cabinet. We will encrypt 
data and keep it in secured computer databases. We will use a number to identify your records 
rather than your name. The platform we use to record your questionnaires called RedCap will 
keep your information confidential (private).  
 
We will keep a master list connecting your name to your study ID number in a separate, secure 
location. We will keep your research records for at least seven years after the study has ended. 
We will limit access to your personal information to the researchers listed on the first page of 
this form. If we let other researchers use the information we have collected from this study for 
related research, it will not contain your personal information. We will not use your name in 
any publication of the research results. 
 
If necessary, we may give reports related to this research to the University of Calgary Conjoint 
Health Research Ethics Board or the Western University Health Sciences Review Ethics Board. 
These organizations will treat such information with strict confidentially.  
 
We will also ask for your doctor’s name which we will keep along with your file. This is in case of 
any mental health concerns we might have later into the study.  
 
If you decide to revoke this consent at any time and withdraw your data from the study, we will 
destroy your research data whenever possible. To revoke your consent, please speak to a 





If you have any further questions or want clarification regarding this research and/or your 
participation, please contact the Local Investigator, Dr. Laura Brunton.  
 
 
If you have any questions about your rights as a research participant or the conduct of the 




Selecting the “I consent…” option below indicates that 1) you understand to your satisfaction 
the information provided to you about your participation in this research project, and 2) you 
agree to participate in the research project. 
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In no way does this waive your legal rights nor release the investigators, sponsors, or involved 
institutions from their legal and professional responsibilities. You are free to withdraw from this 
research project at any time. You should feel free to ask for clarification or new information 
throughout your participation.  
 
 I consent to participate in this research study 




TITLE:  Anxiety and Depression in Youth with Cerebral Palsy:                                         
Role of Physiological Risk Factors 
 
SPONSOR:  Hotchkiss Brain Institute (HBI) 
   3330 Hospital Dr NW 
Calgary, AB T2N 4N1 
 
INVESTIGATORS: Carly McMorris, PhD1, Laura Brunton, PhD2, Melanie Noel, PhD1, Daniel 
Kopola-Sibley, PhD1, Elizabeth Condliffe, PhD1, Benjamin Fong, MSW2, 
Stephanie Howe1, Mica Pabia1, Kate Hall1 
   1University of Calgary, Werklund School of Education 
   2 Alberta Health Services (AHS) 
 
Local PI: Dr. Laura Brunton 
  
CONSENT FORM:  Caregiver Consent to Participate  
 
This consent form is only part of the process of informed consent. It should give 
you the basic idea of what the research is about and what your participation will 
involve. If you would like more detail about something, please ask. Take the time 




Anxiety and depression are very common in kids and teens with cerebral palsy (CP), affecting 
about 57%. It is unknown why anxiety and depression develop and continue in this population. 
Importantly, existing mental health treatments haven’t been adapted for kids with CP and 
mental health concerns. Untreated anxiety and depression in these kids and teens can lead to 
difficulties in many areas of life at home and at school. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
The purpose of this study is to identify physical risk factors that may lead to the development of 
anxiety and depression in kids with CP. This will be the first study to look at the relationship 
between physical symptoms (pain, low energy levels, and trouble sleeping) and anxiety and 
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depression in kids with CP. Findings from this study will help identify risk factors that we can 
treat, and improve the lives of this vulnerable population. 
 
WHAT WOULD I HAVE TO DO? 
Participation involves two parts: three parts: 1) a mental health interview, 2) online 
questionnaires, and 3) a 7-day assessment of your child’s physical health symptoms. 
 
1. Mental Health Interview: We will arrange a time with you where we will call you either 
on the phone or on video chat. Our video chat calls will be held over Zoom. We will ask you 
questions about your child’s mental health symptoms, emotions, and behaviours. We will 
record the interview so that we can remember the  information correctly.P 
 
2. Questionnaires: We will send questionnaires to your email address. These 
questionnaires will ask about your child’s mental health symptoms and what kinds of services 
they have received. Additionally, we will ask you to complete several questionnaires about 
yourself. This will include questions about your family’s income, how many people are in your 
family, your education and employment, your own mental health and your parenting style.  
 
3. Seven (7)-day assessment of physical health symptoms: Your family will receive a 
package with the materials they will need in the mail. We will ask your child to wear two 
Actigraphs at all times for 7 days and 7 nights: one on their waist, and one on their wrist. These 
Actigraphs are small devices that will record your child’s activity. The Actigraph will give us 
information about your child’s physical activity and how well they are sleeping. We will also ask 
your child to answer a few questions each day about their mood, sleep, pain, and energy levels 
for the 7 days, through a short (5 minute) survey that we will send to them over email at the 
same time each day. 
 
WHAT ARE THE RISKS? 
All the parts of this study have been reviewed and there are minimal risks involved. 
• The only risk of completing the questionnaire assessments is that you may become 
tired. For this or any other reason, you may stop at any time. You will be working on the 
questionnaires in your own time at home and will have up to two weeks to complete 
them. The questionnaires and the interview will take a total of about 3 hours. 
• Some of the questionnaires may reveal issues about your child that you were not 
worried about before. If that is the case, the records will be reviewed by Dr. McMorris, 
who will discuss with you about how to follow-up.  
• As we are currently facing a global pandemic, we have made adaptations to the study 
that allow us to collect information from you without any face-to-face contact. 
However, we will be sending a package to your home containing the Actigraph and we 
cannot guarantee that it is free from contamination. Our team will take extra care to 
sanitize these materials. If you and your child are interested in taking part in the study, 
but would rather wait until risks associated with the coronavirus have lowered, please 
let us know. We would be happy to save your contact information and contact you at a 
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later date. You and your child  may also choose to do every part of the study, except for 
wearing the Actigraph if you would like. 
• There is always the possibility of a privacy breach with online data collection; however, 
we will use best practices including passwords, firewalls and limiting access to your data 
to only essential personnel to reduce this risk. In addition, the platform used to collect 
the questionnaire data, RedCap, ensures confidentiality and privacy of your and your 
child’s results. 
 
ARE THERE ANY BENEFITS? 
This study will be filling a gap in the current research by helping us find health behaviours that 
can be targeted with treatments that already exist. You will receive a report with information 
about your child’s performance on the measures we collect. You may choose to share this 
report with support services and schools. 
 
DO I HAVE TO PARTICIPATE? 
Whether you would like to participate in this study is your decision. You can withdraw at any 
time without it affecting your relationship with your healthcare providers. If any new 
information comes up that might affect your choice to participate, we will let you know as soon 
as possible. 
 
WILL I BE PAID FOR PARTICIPATING, OR DO WE HAVE TO PAY FOR ANYTHING? 
Your family will receive a $50 gift card to compensate you for your time. You will not have to 
pay for anything; postage will be pre-paid. 
 
WILL MY RECORDS BE KEPT PRIVATE? 
We will keep any information about you that we collect as confidential (private) as possible. We 
will store all information that we collect about you in a locked filing cabinet. This cabinet will be 
in the CHEaR Lab at Western University. We will encrypt data and keep it in secured computer 
databases. We will use a number to identify your records rather than your name. 
 
We will keep a master list connecting your name to your study ID number in a separate, secure 
location. We will keep your research records for at least five years after the study has ended. 
We will limit access to your personal information to the researchers listed on the first page of 
this form. If we let other researchers use the information we have collected from this study for 
related research, it will not contain your personal information. We will not use your name in 
any publication of the research results. 
 
If necessary, we may give reports related to this research to the University of Calgary Conjoint 
Health Research Ethics Board or the Western University Health Sciences Research Ethics Board. 
These organizations will treat such information with strict confidentially.  
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We will also ask for the contact information of your child’s physician. This is in case of any 
concerns our team may come across during your child’s assessment. You will be notified if we 
choose to contact them.  
 
If you decide to revoke this consent at any time and withdraw your data from the study, we will 
destroy your research data whenever possible. To revoke your consent, please speak to a 





If you have any further questions or want clarification regarding this research and/or your 
participation, please contact the Local  Investigator, Dr. Laura Brunton.  
 
 
If you have any questions about your rights as a research participant or the conduct of the 
study, you may contact The Office of Research Ethics. 
 
A copy of this consent form has been given to you to keep for your records and reference. The 




Selecting the “I consent…” option below indicates that 1) you understand to your satisfaction 
the information provided to you about your participation in this research project, and 2) you 
agree to participate in the research project. 
In no way does this waive your legal rights nor release the investigators, sponsors, or involved 
institutions from their legal and professional responsibilities. You are free to withdraw from this 
research project at any time. You should feel free to ask for clarification or new information 
throughout your participation.  
 
 I consent to participate in this research study 










Fatigue Impact and Severity Self-Assessment (FISSA) 
 
Please answer the following questions about your experience with fatigue. For the 
purposes of this questionnaire we would like you to think about fatigue in terms of: 
· physical tiredness  
· muscle soreness  
· exhaustion of your muscles and body 
· or any related feeling 
When answering the questions, please try to focus on fatigue as it is defined above and 
not pain you may experience that is different from muscle soreness.  
 
Impact Scale 
Completely      Somewhat        Neither Agree             Somewhat    Completely 
Disagree        Disagree      nor Disagree       Agree         Agree 
      1     2   3                  4  5 
  
Using the scale above and thinking about a typical week (7 days), to what extent do you 
agree with the following statements?  
 
Fatigue interferes with …  
1.  my general everyday activities 1 2 3 4 5 
2.  my ability to move around indoors 1 2 3 4 5 
3.  my ability to do things on my own 1 2 3 4 5 
4.  my ability to move around in my community 1 2 3 4 5 
5.  my ability to get outside of my house 1 2 3 4 5 
6.  my ability to finish things 1 2 3 4 5 
7.  my participation in social activities 1 2 3 4 5 
8.  my ability to start things 1 2 3 4 5 
9.  my ability to take care of myself (examples: dressing, eating, bathing, 
brushing my teeth/hair, toileting etc.) 
1 2 3 4 5 
 
In addition,  
10. I use adaptive equipment to manage my fatigue (examples: a walker, 
manual wheelchair, power wheelchair etc.) 
1 2 3 4 5 
11. I have had to reduce my work responsibilities outside of my home 
because of fatigue (examples: school work, job-related work, 
volunteering etc.) 
1 2 3 4 5 





Using the scale given with each question, please think about the last seven (7) days 
and answer the following statements or questions. 
 
13. Rate your level of fatigue on the day within the last week that you felt the most 
fatigued: 
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
14. Rate your level of fatigue on the day within the last week that you felt the least 
fatigued:  
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
15. Rate your average level of fatigue for the past week: 
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
16. On average, how much of the day do you feel fatigued? 
None          A Quarter    Half the Day         Three Quarters           All Day  
                    of the Day                of the Day 




17. For how many days last week did you feel fatigued at least part of the day? 
 






Management and Activity Modification Scale 
Using the scale below and thinking about a typical week (7 days), to what extent do you 
agree with the following statements?  
 
Completely      Somewhat        Neither Agree             Somewhat    Completely 
Disagree        Disagree      nor Disagree       Agree         Agree 
      1     2   3                  4  5 
!
Fatigue interferes with …  
18.  my enjoyment of life 1 2 3 4 5 
19.  my leisure and recreational activities 1 2 3 4 5 
20.  the length of time I can be physically active 1 2 3 4 5 
21.  my balance and coordination 1 2 3 4 5 
22.  my motivation to do physical activities  1 2 3 4 5 
23.  my motivation to participate in social activities  1 2 3 4 5 
!
In addition,  
!
24.  my muscles ache when I am fatigued 1 2 3 4 5 
25.  long periods of inactivity increase my fatigue 1 2 3 4 5 
26.  stress increases my fatigue 1 2 3 4 5 
27.  fatigue increases my stress 1 2 3 4 5 
28. I pace my physical activities to manage my fatigue 1 2 3 4 5 
29. I think about fatigue when I plan my day 1 2 3 4 5 
30. I limit my physical activity to manage my fatigue 1 2 3 4 5 











32. Does your level of fatigue change depending on the time of day?  
Yes    (If yes, please answer question 32b)  No 
 
 
32b. What time of day is your fatigue the worst? 
Early Morning    Mid-morning         Noon     Late afternoon        Evening 




33. Does your level of fatigue change depending on the day of the week? 




33b. On which day of the week are you most fatigued? 
Monday     Tuesday    Wednesday      Thursday    Friday      Saturday      Sunday 
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Thank you for participating in this research study!  
Your participation will help us understand how pain and sleep impact the mental health of kids with 
cerebral palsy. 
The first thing that you will need to do as part of this study is put 
on your Actigraphs. When you receive your Actigraphs, they will 
already be charged, turned on, and ready to go. 
There will be two Actigraphs in your package.  
• One of the Actigraphs will be in a pouch on a belt. This 
Actigraph will go around your waist. It will also already be placed 
in a pouch the right side up. Please do not remove the Actigraph 
from its pouch. This Actigraph should be worn close to the hip of 
your dominant leg. 
• The other Actigraph will be on a wristband and will look kind of 
like a wristwatch. This Actigraph is also already on and there is 
nothing you need to do other than to put it on your wrist. It should be worn on the wrist of your 
dominant hand (your dominant hand is the hand that you would write with). 
You will be wearing your Actigraphs for 7 days and 7 nights, only removing them to bathe/shower or go 
swimming. Please take care not to get the Actigraphs wet. Take care not to damage or lose your 
Actigraphs.  
For more instructions about how to wear the Actigraphs, please watch this video created by our 
research team:  
https://www.dropbox.com/s/nm9lx6yyuwk0cie/ActigraphVideo.mp4?dl=0  
You can choose to wear your Actigraphs under your clothes or over your clothes but it’s important that 
you wear your Actigraphs close to your body. Please don’t wear them over top of bulky clothing like 
large jackets or sweaters. If you are lying down and your Actigraph becomes uncomfortable, you may 
move it temporarily to the other side or the centre of your stomach. 
Every day you will receive an email that will remind you to answer some questions for us about the 
amount of sleep you had and the amount of pain you had that day. Every day, you will also need to fill 
out 2 different log sheets. One sheet is to tell us what time you woke up and what time you went to 
sleep each day. The other sheet is to tell us about any times that you removed your Actigraphs over the 
7 days. It is very important that you remember to fill out these sheets, otherwise we won’t be able to 
use your data. 
When the 7 days are over, take off the Actigraphs and place them in the return postage paid envelope 
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Wear the Actigraphs for seven (7) days in a row. In the table below, write down the date and the times, 
including “a.m.” or “p.m.”, that you put it on and take it off during the day. Also note the reason you 
took it off. The Actigraph should only be removed for bathing/showering or swimming. Below is a 
sample entry: 
Date Day Actigraph 
(wrist, waist, 
or both) 
Time Off Time On Reason 
July 15, 2015 Wednesday Both 7:30 a.m. 8:30 a.m. swimming 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 Monitor Off (complete): 
Date Day Time Off  








Principal Investigators: Dr. Laura Brunton & Dr. Carly McMorris 
Ethics ID: HSREB 115678 




Wear the Actigraph when you sleep. Please indicate in the columns below what time you woke up in the 
morning and what time you went to bed including “a.m.” or “p.m.”. If you did not take a nap, you can 






















      
 
Wake time: 6:30 a.m.        
How many times 
did you nap 
today? 
2       
 
Bed time: 8:30 p.m.       
 
How many times 
did you wake 
during the night? 






OFFICE USE ONLY 
Start Date and Time: _______________________       Participant ID: ________________________ 
Actigraph ID: _____________________________        Valid days: __________________________ 
Monitor Off (complete): 





Standard Operating Procedure (SOP) for Actigraph GT3X+ Accelerometer 
 
All ActiGraph activity monitors are designed to monitor human activity and record energy 
expenditure (calories spent during normal activity, METs, everyday activity, and exercise). 
Additionally, these devices can also function as a very accurate sleep assessment tool. While 
collecting day-to-day energy expenditure data, the device should be affixed securely to the 
body’s center-of-mass to ensure the most accurate caloric measurements. 
The GT3X+ based activity monitors provide objective measurements of human activity and are 
used in many research and clinical applications. They include both a micro-electro-mechanical 
system (MEMS) based accelerometer and an ambient light sensor. 
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Logistics/Instructions for participants…..2  
Using Actilife Software…………………………3 
• Initializing a monitor 
• Downloading data 
• Wear Time Validation 
• Scoring and Exporting 
• Graphing 
Creating a report…………………………………6 
Additional Information…………………….....6 
 
Review Update: September 2015 
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Logistics/Instructions for participants 
This section contains the information you need to give to the participant and 
tips to improve compliance.  
i. Tracking Actigraphs 
• A sticker should be placed on the back of each monitor to identify the monitor code e.g. 
AG01 in addition to lab contact details in the case where the monitor has been lost. 
• A second small sticker should be place on top of the actigraph beside the USB cap to 
highlight how the monitor should be worn  
• Monitors should be logged in and out via an excel database with the following variables: 
o Monitor Code 
o Serial number 
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o Participant ID 
o Date initialized/activated 
o Stop time 
o Researcher 
o Monitor returned 
o Monitor log complete 
o Date/time removed (self-report) 
o Battery life 
o Notes 
 
ii. Pre-data collection 
• To achieve a minimum of 5 valid days of data collection, the participant is asked 
to wear the monitor for 7 full consecutive days if possible (a valid day is defined 
as 10 valid hours) 
• The participant will complete a monitor log to fill in a start and end wear time 
and any period of time where the device is removed for more than 5 minutes 
(see Appendix A). This will be an important cross check for validating wear time. 
• Participants are instructed on how to wear the monitor while shown the 
instructions for wear sheet (see Appendix B) 
o The ActiGraph will be given to the participant already threaded onto the 
elastic belt. Participants should be instructed to wear the ActiGraph with 
the blue sticker facing up, the elastic belt fastened around the waist and 
the monitor positioned over the right hip bone. 
o The ActiGraph can be worn either over or under clothing, whichever is 
most comfortable to the participant. The meter does not need to be in 
direct contact with the body. However, it is essential that the ActiGraph 
be positioned snugly enough against the body that it cannot flop around. 
o Participants will be instructed to wear the unit all day and night. Some 
slight re-positioning of the device is allowable if the participant has 
trouble sleeping e.g. if they sleep on their right side, they may slightly 
reposition to the front 
o The only times they should remove the monitor are if the monitor would 
become completely wet (e.g. swimming, showering). These times should 
be logged. 
o Show participants an example report of the output 
o Organize a pick-up time and location for returning the device. If collection 
or drop-off is not possible, give a stamped, addressed and padded 
envelope for return mail. 
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• Some useful examples of what to tell the participant: 
o “We would like you to wear a movement monitor for 7 days. It is similar 
to a pedometer, except it measures general movement.”  
o “To the best of your ability, go about your usual days -- don’t do anything 
different.” 
o “Leave next to your clothes to remind you to put it back on after 
showering” 
o “It runs on a watch battery and isn’t a tracking device. It can’t tell what 
type of activity you are doing or where you are.”  
o “It’s really small, I’ve worn it myself and after a little while I forgot I was 
even wearing it.” 
 
iii. Post-data collection 
• Thank the participant for completing the research and let them know they will 
receive their physical activity report via email 
• Log the return date into the master database 
• Wash the waist band after each use by hand (warm soapy water) or cold cycle. 
Drip dry 
• Download the data and charge for next use. Ensure stickers are intact. 
Using Actilife Software 
i. Initializing a monitor 
This section contains information on how to set up the monitor to begin recording data. For an 
online tutorial, click here 
1. Open Actilife software. Download the latest version of software if you are prompted to 
do so. Always work under the latest version to ensure compatibility between computers 
when using the datavault. 
2. Open the actigraph USB cap using the key provided and plug in using USB cable. The 
monitor should appear under devices. Ensure the battery level is at least 3.85V (>80%) 
or initialization will not be allowed. 
3. Select the check box for the device and click on “Initialize – Regular Initialization” in the 
toolbar. 
4. Select your initialization parameters. First input the recording time by selecting a start 
time and date and a stop time and date. For a 7 day data collection period, it is 
recommended to set the device to record 8 or 9 days to allow time to make up for 
periods of non-wear. 
5. Set Sample Rate to 30Hz. Under LED options and wireless options, nothing is selected. 
Idle sleep mode is set to disabled. 
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6. Enter subject info including participant ID, sex, height weight, DOB and race. ‘Limb’ is set 
to waist and ‘Side’ is set to right. 
7. Select ‘Initialize 1 device’ 
8. Check that initialization is complete under ‘status’ and check recording parameters 
again under devices before plugging out. You can hover over icons under “mode” to 
determine if the features you need are activated. 
9. Safely remove device, plug out and close cap firmly 
 
ii. Downloading data 
This section contains information on how to download the data to your computer after the 
participant has worn the actigraph. See online tutorial here 
1. Open Actilife software 
2. Open the actigraph and plug in using the USB cable. The monitor should be recognized 
and appear under devices. Confirm that the device contains data for this wear period 
3. Click the download option in the toolbar and a new window will open 
4. Download naming convention should be set to <Subject Name><Start Date> 
5. For Download Options, ensure ‘Create AGD File’ is checked Epoch length should be set 
to 10 seconds and # of Axis should be set to 3. Ensure boxes for ‘Steps’, ‘Lux’, 
‘Inclinometer’ and ‘Low Frequency Extension’ are also checked. You can also edit any 
participant information here under ‘Add biometric and user information’ here. 
6. Select ‘Download All Devices’ 
7. The progress bar in the main window will show you when the download is complete. 
Under ‘Status’ should read ‘finished downloading’ 
8. Click the ‘finished downloading’ hyperlink and select ‘Export GT3X file’. A new window 
will open. Ensure ‘Create AGD’, ‘Create CSV’, ‘Create DAT’ and ‘Low Frequency 
Extension’ are selected. Then click in ‘Export RAW Files’ 
9. These files will save to Actigraph>Actilife>Downloads in your Documents folder  
 
iii. Wear Time Validation 
The next step in the analysis process is to set the appropriate wear time for the downloaded 
data. This is done using a combination of wear period algorithms and using the monitor log 
provided by the participant. 
1. Click on the Wear Time Validation tab 
2. ‘Define a Non-Wear Period’ should be set to Choi (2011). Minimum Length (90 
minutes), Small Window Length (30 minutes) and Spike Tolerance (2 minutes). Select 
‘Use Vector Magnitude’ 
3. For ‘Optimal Screen Parameters’, nothing is selected 
XXVIII 
 
4. Uncheck all Data Sets and check the one(s) you wish to analyze. If it is not there, click 
on ‘Add Dataset’ and find the AGD file in the downloads folder 
5. Hit Calculate and a new window will open 
6. At the end of the window, under ‘All Periods’ contains a list of Wear and Non-Wear 
periods as calculated using the Choi algorithm. You will need to cross-check these 
periods with the monitor log provided by the participant. Normally, shower periods are 
not recognized if the monitor is off for periods shorter than 90 minutes. Also, a very 
inactive period (often evening time or during sleep) can be detected in error as a Non-
Wear period.  
7. Go to the first Non-Wear period. If the participant has not recorded this date and time 
as a Non-Wear period, click on ‘Set As Wear’ if appropriate. Scroll down and continue 
this process for all Wear and Non-Wear periods. Use best judgement call to change 
between ‘Wear’ and ‘Non-Wear’ as appropriate. Also note beginning and end of wear 
period provided by the participant as the device may continue recording past this time 
depending on set-up. 
8. Click on ‘Save’ and select the next dataset or click on ‘Save and Close’ 
 
iv. Scoring and Exporting 
We now wish to analyze the selected data period and select appropriate algorithms to 
apply cut-offs for calculation of energy expenditure, METs and exercise intensity. 
Recommendations are provided below but can be altered depending on the population in 
question. See https://help.theactigraph.com/entries/21452826 for more details. 
1. Click on the ‘Scoring’ tab 
2. On the left, under Algorithms, ensure the following boxes are checked: 
• Energy Expenditure 
• METs 
• Cut Points and MVPA 
• Bouts 
• Sedentary Analysis 
3. The following algorithms are recommended for use for an adult population: 
• Energy Expenditure – Freedson VM3 (2011) 
• METs – Freedson Adult (1998) 
• Cut Points and MVPA – Troiano Adult (2008) 
4. The following algorithms are recommended for use for a pediatric population: 
• Energy Expenditure – Freedson VM3 (2011) 
• METs – Freedson (2005) 
• Cut Points and MVPA – Evenson Children (2008) 
5. Under Filters, check ‘Exclude Non-Wear Times from Analysis’ 
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6. Select your required dataset from list or go to ‘Add Dataset’ 
7. Click on ‘Calculate’ 
8. Click on ‘Export’ in right bottom corner 
9. Select required excel files for analysis and hit export. Name your file. It is better to 
do an export in bulk, selecting numerous datasets so they will all be contained in 
one excel file 
10. One Summary file and one data file with numerous tabs will be saved under 
CSVFiles in your Actilife folder 
Creating a report 
1. The type of report you want to create will be based on the research study in question. 
An example report form is in Appendix C. 
2. To create the graph, a screen grab is taken from the ‘Graphing’ tab in Actilife software 
for the relevant days. Use the clipping tool in Windows software. Ensure the checked 
box for ‘Equal Activity Scales’ is selected and set in the region 1500-3000 counts, 
dependent on the activity level for the individual. 
3. Create a table in excel to include date, day, wear time (hrs), activity kcals, average 
kcals/hr, steps and sedentary, light, moderate and vigorous time presents as mins and 
%.  Calculate total and average values. You can also choose to graph these values in a 
pie chart a % of total time 
4. To allow the participant to interpret these values, show how they compare to Canadian 




This section contains additional useful information on specification and functionality of the 
Actigraph device. This information and more is available by accessing the Actigraph GT3X 
manual. 
Steps:  Step counts are accumulated on a per-epoch basis and are based on accelerometer data 
collected on the vertical axis.  An algorithm present in the device firmware filters out the 
accelerometer’s baseline noise level to help accurately accumulate the steps-per-epoch.    
Inclinometer : The post-processed inclinometer feature helps users identify the orientation of 
the device and, more importantly, when the device itself was taken off.  Each epoch is flagged 
with a number (1 through 4) to indicate the orientation of the device during that epoch.    
Important:  The inclinometer feature is only valid if the device is worn on the hip with Axis 1 
upward facing.  
 
Interpretation of Inclinometer Code (Stored with each Epoch)  
0 Device Off (Not Being Worn)  
1 Subject Standing  
2 Subject Lying Horizontal  
XXX 
 
3 Subject Sitting  
 
Low Frequency Extension: The Low Frequency Extension (LFE) option, though not a mode or 
channel, is another data collection option during post-processing for the GT3X+ and wGT3X+.  
The standard proprietary filter algorithm used in ActiGraph products is used to eliminate any 
acceleration noise outside of the normal human activity frequency bandwidth.  This filter is 
customized to work with ActiGraph’s Energy Expenditure Algorithms.  The LFE option, when 
enabled, increases sensitivity to very low amplitude activities allowing for the study of 
population groups who move slowly or take very light steps (for example, the elderly).  For 
more details, contact ActiGraph at support@theactigraph.com.     
Data Collection:  Initialize time options/selections have been reduced significantly due to the 
new data collection method used by the GT3X+ and beyond devices.  During initialization, the 
user is now only required to select the desired raw data sample frequency (30Hz up to 100Hz in 
10Hz increments).  Data is automatically collected from all on-board sensors in raw data format.  
The data recorded includes:  
Vertical Axis Activity Acceleration Data (Axis 1)  
Horizontal Axis Activity Acceleration Data (Axis 2)  
Perpendicular Axis Activity Acceleration Data (Axis 3)  
Ambient Light (Lux) 
 
Unlike previous ActiGraph products, the wGT3X+ and wActiSleep+ do not filter or accumulate 
data into epochs.  Raw data is collected at the selected sample rate and is post-processed in the 
ActiLife.  Because these devices collect data from all sensors at all times, users can generate 
native ActiLife *.agd files containing any desired combination of parametric data at a later time.  
This helps facilitate backward compatibility and enhances the flexibility of the data by allowing 
users to compare data to studies which use different filter techniques or accumulation sizes 
(e.g., 1 second epochs versus 60 second epochs). 
 
Water Resistance:  The wGT3X+ and wActiSleep+ are water resistant in accordance with IEC 
60529 IPX7, or immersion in one (1) meter of water for up to 30 minutes 
 
Battery: All ActiGraph devices use a lithium ion rechargeable battery that has a maximum 
voltage of approximately 4.20 volts.  At 3.1 volts the devices enter a low voltage mode state 
(HALT mode).  
 
Low Voltage Mode (HALT): ActiGraph devices enter a “Low Voltage Mode” (or HALT) state when 
the battery discharges beyond a point of being able to power the device.  In this mode, all 
important variables and data are stored in flash memory to secure the device download.  
Because the device’s internal clock stops in HALT mode, the device cannot be recharged and 
redeployed; the device must be downloaded and reinitialized to continue use.    
 
Recharging and LED Decoding: Recharging is automatic and is accomplished by connecting the 
device to a standard USB port. Charging time will depend on the battery life, but typically will 
not exceed four hours for a fully depleted battery to become fully charged.  Once the battery is 
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completely charged, the green LED will remain illuminated.  If the battery voltage drops below 
3.1 volts while in use, the device will not have sufficient power to collect data and will warn the 
user through a series of coded flashes.  The battery level, reported in volts, can be viewed at 


















































Thesis: Investigating Physiological Determinants of Mental Health in Children with Cerebral 
Palsy 
Supervisor:  Dr. Laura Brunton 
-Expected Graduation- August 2021 
 
HBSc. Human Biology and Italian Studies            2015-2019 










 Responsibilities:  
Conducting research for thesis project. Using software’s including SPSS and ActiLife to 
complete thesis. Assisting in recruitment methods for the purpose of thesis. Assisting Dr. 
Laura Brunton in other projects within the CHEaR Research Lab and inter-lab research. 
Roles included conducting literature searches used for scoping and systematic reviews, 
extracting data from review papers.  
 
Undergraduate Research Summer Student 
Mood Disorders Pharmacology Unit, Toronto Western Hospital 




Conducting searches of the literature and writing a narrative literature review for the 
purpose of publication. Assisting students in writing and literature searches. Providing 






Graduate Teaching Assistant 
Interprofessional Education and Practice (IPE 9802)  





Facilitating discussions for interdisciplinary journal clubs and laboratory meetings. 
Preparing and contributing to laboratory lesson plans and aiding in instructing course 
material. Grading and providing substantial feedback for minor and major assignments. 
Providing support for students regarding course material. 
 
Graduate Teaching Assistant  
Introduction to Health Ethics (HS2610G) 




Proctoring examinations and final evaluations. Grading and providing substantial 
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Facility in Charge 
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Speciality Sports and Arts Camp Counsellor 
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Testani, D., Brunton L (May, 2021). ). Investigating Physiological Determinants of Mental 
 Health in Children with Cerebral Palsy. Oral presentation accepted at the Child Health 
 Symposium, London, Canada. 
 
Testani, D., Brunton L (February, 2021). Investigating Physiological Determinants of Mental 
 Health in Children with Cerebral Palsy. Oral presentation presented at the Health and 
 Rehabilitation Sciences Graduate Research Conference, London, Canada. 
 
Testani, D., Brunton L (May, 2020). Investigating Physiological Determinants of Mental Health 
 in Children with Cerebral Palsy. Oral presentation accepted at the Arthur Labatt Family 
 School of Nursing Legacy Research Conference, London, Canada. 
 
Testani, D., Brunton, L (February 2020) Investigating Physiological Determinants of Mental 
 Health in children with Cerebral Palsy. Competitive oral presentation presented at the 3 
 Minute Thesis Competition, London, Canada 
 
Testani, D., Brunton L (February, 2020). Investigating Physiological Determinants of Mental 
 Health in Children with Cerebral Palsy. Oral presentation presented at the Health and 




Testani, D., Brunton, L (May, 2021). Investigating Physiological Determinants of Mental Health 
 in Children with Cerebral Palsy. Poster presented at the London Health Research Day, 
 Schulich School of Medicine, London, Canada 
 
Testani, D., Brunton, L (April, 2021). Investigating Physiological Determinants of Mental Health 
 in Children with Cerebral Palsy. Poster presented at the 5th Annual Parkwood Research 












 Responsible for facilitating and organizing the annual Health and Rehabilitation Sciences 
Graduate Research Conference. Acted in the primary leadership role in executing 
the first virtual conference for Health and Rehabilitation Science Students. Lead in 
conceptualizing virtual conference, contacting and interacting with speakers, faculty, 
presenters, collecting abstract submission and providing feedback, organizing 
sponsorship, delegating roles to committee members. 
 
Abstract Reviewer 





Grading and providing constructive feedback for presenter abstracts. Delegating abstract 
reviewer teams and ensuring feedback was well received and integrated for re-
submission. 
 
EXTRACURRICULAR AND COMMUNITY SERVICES 
 
Internal Extracurricular Services 
 
Academic Vice President 
Health and Rehabilitation Sciences Graduate Student Society 




Responsible for facilitating and organizing major, academically oriented events and 
initiatives, including research days, conferences, forums, and symposia. Provide a 
leadership role with each of these major initiatives and act as a primary liaison to faculty 
members that are involved in said initiatives. Responsible for creating and executing for 
the annual Health and Rehabilitation Sciences Graduate Research Conference.  
 





The CCHCSP provides support for these highly qualified child health clinician 
candidates to develop their requisite knowledge and skills for a career as an independent 
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scientist in child health research. Trainees engage in research training and a core 
curriculum that delivers a common multidisciplinary language of research, while 
imparting professional skills and values. Attended monthly meetings and participated in 
discussion 
 
External Extracurricular Services 
 
President 
Italian Undergraduate Student Cultural Association 
University of St. Michael's College, University of Toronto 
2018-2019 
 
BIRT/SODR Therapeutic Recreation Volunteer 




Italian Studies Department 
University of St. Michael's College, University of Toronto 
2018-2019 
 
Commuter Don Executive 





• Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans Course 
on Research Ethics (TCPS 2: CORE) 
• Patient-Oriented Research Curriculum In Child Health (PORCCH) Completion of 
Modules, University of Western Ontario  
• Workplace Hazardous Materials Information System (WHIMIS) 
• Standard First Aid: CPR-C + AED, Canadian Red Cross 
• High Five Principles of Health Child Development 
• Coach for the Coaching Association of Canada (NCCP) 
 
 
